id,label,pathway,acc,uri
1dabd02b-5116-5219-b932-191dc12d227c,15q11.2 copy number variation syndrome WP4940,15q11.2 copy number variation syndrome,WP4940,https://www.wikipathways.org/index.php/Pathway:WP4940
61758bae-776b-5f11-a767-26405fd47063,15q13.3 copy number variation syndrome WP4942,15q13.3 copy number variation syndrome,WP4942,https://www.wikipathways.org/index.php/Pathway:WP4942
5732069e-aec7-54a7-8243-f830caf42a2b,16p11.2 distal deletion syndrome WP4950,16p11.2 distal deletion syndrome,WP4950,https://www.wikipathways.org/index.php/Pathway:WP4950
0cb66900-3ceb-561d-acff-723619ae54de,16p11.2 proximal deletion syndrome WP4949,16p11.2 proximal deletion syndrome,WP4949,https://www.wikipathways.org/index.php/Pathway:WP4949
678cd5f5-6a1e-5c39-87d2-2fc823a43442,1q21.1 copy number variation syndrome WP4905,1q21.1 copy number variation syndrome,WP4905,https://www.wikipathways.org/index.php/Pathway:WP4905
1463d9fc-e7a9-5bc2-ae22-5bec0236e840,22q11.2 copy number variation syndrome WP4657,22q11.2 copy number variation syndrome,WP4657,https://www.wikipathways.org/index.php/Pathway:WP4657
514618a7-c788-56a8-bd46-b5ab700e7f8d,3q29 copy number variation syndrome WP4906,3q29 copy number variation syndrome,WP4906,https://www.wikipathways.org/index.php/Pathway:WP4906
bc23930c-aaab-582d-88e0-3e29c4ecb816,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879","4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression",WP3879,https://www.wikipathways.org/index.php/Pathway:WP3879
3ef123d6-4dfd-54b2-88dd-7e8a190d9937,7-oxo-C and 7beta-HC pathways WP5064,7-oxo-C and 7beta-HC pathways,WP5064,https://www.wikipathways.org/index.php/Pathway:WP5064
1cb30cee-b893-5bc6-a896-52eebee4192b,7q11.23 copy number variation syndrome WP4932,7q11.23 copy number variation syndrome,WP4932,https://www.wikipathways.org/index.php/Pathway:WP4932
cd6530c5-d0cb-5e14-ac03-571425bf0e97,ACE Inhibitor Pathway WP554,ACE Inhibitor Pathway,WP554,https://www.wikipathways.org/index.php/Pathway:WP554
8b007353-f513-5da0-88a4-53913e51bec8,Acetylcholine Synthesis WP528,Acetylcholine Synthesis,WP528,https://www.wikipathways.org/index.php/Pathway:WP528
92d0b1af-c8b7-5547-8eb2-b99bb700c851,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,Activation of NLRP3 Inflammasome by SARS-CoV-2,WP4876,https://www.wikipathways.org/index.php/Pathway:WP4876
7eabb638-3fb9-5f07-a61a-e933aa3fb348,Acute viral myocarditis WP4298,Acute viral myocarditis,WP4298,https://www.wikipathways.org/index.php/Pathway:WP4298
2a40bbee-aa73-5151-916c-bfd6442370a9,Adipogenesis WP236,Adipogenesis,WP236,https://www.wikipathways.org/index.php/Pathway:WP236
a62a2d70-bce5-5dc9-8085-e4e609eade7d,Aflatoxin B1 metabolism WP699,Aflatoxin B1 metabolism,WP699,https://www.wikipathways.org/index.php/Pathway:WP699
c345c26b-4cf5-5ce0-a4cb-84c2e285c306,AGE/RAGE pathway WP2324,AGE/RAGE pathway,WP2324,https://www.wikipathways.org/index.php/Pathway:WP2324
5f92a5d8-5de5-52ae-9f9d-e480692fba25,Airway smooth muscle cell contraction WP4962,Airway smooth muscle cell contraction,WP4962,https://www.wikipathways.org/index.php/Pathway:WP4962
3f9785c5-006a-573d-bae8-206c8d16150e,Alanine and aspartate metabolism WP106,Alanine and aspartate metabolism,WP106,https://www.wikipathways.org/index.php/Pathway:WP106
e6af4987-ef0f-5305-b1ee-dea97c2606a5,Allograft Rejection WP2328,Allograft Rejection,WP2328,https://www.wikipathways.org/index.php/Pathway:WP2328
0aace216-650b-5dc8-9c40-cc530d937229,Alpha 6 Beta 4 signaling pathway WP244,Alpha 6 Beta 4 signaling pathway,WP244,https://www.wikipathways.org/index.php/Pathway:WP244
1f8cd171-96c6-53d6-9d72-7564231b5b29,Alzheimer's disease WP2059,Alzheimer's disease,WP2059,https://www.wikipathways.org/index.php/Pathway:WP2059
6054f24e-2689-5c72-abcd-2455092146be,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension),WP4661,https://www.wikipathways.org/index.php/Pathway:WP4661
5d068a9a-0918-58ef-94b8-3a74b1e30e74,Amino Acid metabolism WP3925,Amino Acid metabolism,WP3925,https://www.wikipathways.org/index.php/Pathway:WP3925
e8f2e6f4-f42f-5778-86ac-9789f5a164a4,AMP-activated protein kinase (AMPK) signaling WP1403,AMP-activated protein kinase (AMPK) signaling,WP1403,https://www.wikipathways.org/index.php/Pathway:WP1403
322037f7-1723-526c-9001-ddf36aa70f3e,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits,WP3678,https://www.wikipathways.org/index.php/Pathway:WP3678
d6d48146-0377-5e99-84b5-4d8f59185b52,Amyotrophic lateral sclerosis (ALS) WP2447,Amyotrophic lateral sclerosis (ALS),WP2447,https://www.wikipathways.org/index.php/Pathway:WP2447
250eb212-d81c-57a2-98ea-ea83fbf86d60,Androgen receptor signaling pathway WP138,Androgen receptor signaling pathway,WP138,https://www.wikipathways.org/index.php/Pathway:WP138
78033c7c-174e-5813-897e-fce8a1191104,Angiogenesis WP1539,Angiogenesis,WP1539,https://www.wikipathways.org/index.php/Pathway:WP1539
5d89f092-529b-5e82-8165-6452af377bd6,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,Angiopoietin Like Protein 8 Regulatory Pathway,WP3915,https://www.wikipathways.org/index.php/Pathway:WP3915
9b684d54-7687-5923-9fe5-7fdb2d60b2c7,ApoE and miR-146 in inflammation and atherosclerosis WP3926,ApoE and miR-146 in inflammation and atherosclerosis,WP3926,https://www.wikipathways.org/index.php/Pathway:WP3926
74ddb8cc-ab57-524b-b5fb-a41901544512,Apoptosis Modulation and Signaling WP1772,Apoptosis Modulation and Signaling,WP1772,https://www.wikipathways.org/index.php/Pathway:WP1772
dda9172a-18ef-52b8-81e6-f6c4f6accc8f,Apoptosis Modulation by HSP70 WP384,Apoptosis Modulation by HSP70,WP384,https://www.wikipathways.org/index.php/Pathway:WP384
f74c00b2-8b2e-5fef-9246-c23fe6209034,Apoptosis WP254,Apoptosis,WP254,https://www.wikipathways.org/index.php/Pathway:WP254
38e50458-7b78-52e4-bbe7-16fc160d1903,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,Apoptosis-related network due to altered Notch3 in ovarian cancer,WP2864,https://www.wikipathways.org/index.php/Pathway:WP2864
275f67e2-f24a-5955-a519-1acc45553ed2,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,Arachidonate Epoxygenase / Epoxide Hydrolase,WP678,https://www.wikipathways.org/index.php/Pathway:WP678
c38462fd-245e-5b98-92ac-dad6b705975c,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,https://www.wikipathways.org/index.php/Pathway:WP2118
d438ad13-94f8-56dd-8f2a-999167afdca1,Aryl Hydrocarbon Receptor Netpath WP2586,Aryl Hydrocarbon Receptor Netpath,WP2586,https://www.wikipathways.org/index.php/Pathway:WP2586
f67b81cc-7c26-5726-baa5-6aee0ad262f5,Aryl Hydrocarbon Receptor Pathway WP2873,Aryl Hydrocarbon Receptor Pathway,WP2873,https://www.wikipathways.org/index.php/Pathway:WP2873
c43f96ee-7371-5b65-b093-ccb8b139d903,Arylamine metabolism WP694,Arylamine metabolism,WP694,https://www.wikipathways.org/index.php/Pathway:WP694
60c6e973-d7d5-539b-99df-3785bab2b152,Aspirin and miRNAs WP4707,Aspirin and miRNAs,WP4707,https://www.wikipathways.org/index.php/Pathway:WP4707
d451abad-babf-547a-ab3c-de3f8c4dbc9b,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,Association Between Physico-Chemical Features and Toxicity Associated Pathways,WP3680,https://www.wikipathways.org/index.php/Pathway:WP3680
54a9f304-bb42-5baf-ba70-6c385fe4ac5d,ATM Signaling Network in Development and Disease  WP3878,ATM Signaling Network in Development and Disease ,WP3878,https://www.wikipathways.org/index.php/Pathway:WP3878
f87d393d-7eae-58fb-aac0-a48beaf66984,ATM Signaling Pathway WP2516,ATM Signaling Pathway,WP2516,https://www.wikipathways.org/index.php/Pathway:WP2516
b4d509cd-d80a-5965-8533-2fc5a31a4b67,ATR Signaling WP3875,ATR Signaling,WP3875,https://www.wikipathways.org/index.php/Pathway:WP3875
6d3a2b6c-4a4c-540b-b008-c4b253fa324a,Autophagy WP4923,Autophagy,WP4923,https://www.wikipathways.org/index.php/Pathway:WP4923
c51ba777-8c75-543f-9bb5-f22bea5a53a0,Autosomal recessive Osteopetrosis pathways WP4788,Autosomal recessive Osteopetrosis pathways,WP4788,https://www.wikipathways.org/index.php/Pathway:WP4788
fc58166b-8286-5187-9a59-a57f5f3408aa,B Cell Receptor Signaling Pathway WP23,B Cell Receptor Signaling Pathway,WP23,https://www.wikipathways.org/index.php/Pathway:WP23
79ccdbfd-21de-5c1b-87a9-7efd0b0e91cd,Base Excision Repair WP4752,Base Excision Repair,WP4752,https://www.wikipathways.org/index.php/Pathway:WP4752
1d4fc9cc-de8d-50b9-80e3-ec7f43eb115c,BDNF-TrkB Signaling WP3676,BDNF-TrkB Signaling,WP3676,https://www.wikipathways.org/index.php/Pathway:WP3676
1b54c692-dc0b-5f67-bbbd-2121b8cdaa47,Benzene metabolism WP3891,Benzene metabolism,WP3891,https://www.wikipathways.org/index.php/Pathway:WP3891
3e9a60a8-e112-5821-a21d-c3d244bac325,Benzo(a)pyrene metabolism WP696,Benzo(a)pyrene metabolism,WP696,https://www.wikipathways.org/index.php/Pathway:WP696
467ab3da-1e34-525f-ade5-d4b6d8d706ce,Bile acids synthesis and enterohepatic circulation  WP4389,Bile acids synthesis and enterohepatic circulation ,WP4389,https://www.wikipathways.org/index.php/Pathway:WP4389
35e6a07e-e10f-5dac-ba5c-7bcca863665b,Biogenic Amine Synthesis WP550,Biogenic Amine Synthesis,WP550,https://www.wikipathways.org/index.php/Pathway:WP550
682da753-a9f5-57aa-87b4-e63acc8581d7,Biomarkers for pyrimidine metabolism disorders WP4584,Biomarkers for pyrimidine metabolism disorders,WP4584,https://www.wikipathways.org/index.php/Pathway:WP4584
eac09fa1-b0e1-5dfa-8727-0957f2c1dd86,Biomarkers for urea cycle disorders WP4583,Biomarkers for urea cycle disorders,WP4583,https://www.wikipathways.org/index.php/Pathway:WP4583
4caee8e2-3c33-522b-b561-0d7900e4d63f,Biotin Metabolism (including IEMs) WP5031,Biotin Metabolism (including IEMs),WP5031,https://www.wikipathways.org/index.php/Pathway:WP5031
8c5242e2-eeda-55cd-8e9f-9cdda6fd4488,Bladder cancer WP2828,Bladder cancer,WP2828,https://www.wikipathways.org/index.php/Pathway:WP2828
9d44819c-40a3-522c-bb65-bfa068610b77,Blood Clotting Cascade WP272,Blood Clotting Cascade,WP272,https://www.wikipathways.org/index.php/Pathway:WP272
4715c55d-4e70-577c-bd7b-b2ac8ea08ae6,BMP Signaling Pathway in Eyelid Development WP3927,BMP Signaling Pathway in Eyelid Development,WP3927,https://www.wikipathways.org/index.php/Pathway:WP3927
ce2f3fb0-6568-52e2-ae61-e04a7e668832,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation,WP3876,https://www.wikipathways.org/index.php/Pathway:WP3876
18a01d34-f6e3-5eab-973e-1ec13ddadebe,Bone morphogenic protein (BMP) signaling and regulation WP1425,Bone morphogenic protein (BMP) signaling and regulation,WP1425,https://www.wikipathways.org/index.php/Pathway:WP1425
9b4986f4-ffdf-5885-976f-879bc4cd37cf,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,WP2380,https://www.wikipathways.org/index.php/Pathway:WP2380
e0ce9070-cb51-5af8-ad31-8d66c2357b28,Breast cancer pathway WP4262,Breast cancer pathway,WP4262,https://www.wikipathways.org/index.php/Pathway:WP4262
a8aaf3d6-3f87-5a0f-ad65-5ccdfce4f1d0,Calcium Regulation in the Cardiac Cell WP536,Calcium Regulation in the Cardiac Cell,WP536,https://www.wikipathways.org/index.php/Pathway:WP536
c65a5de9-babd-582e-aaa9-9d642c492b30,Caloric restriction and aging WP4191,Caloric restriction and aging,WP4191,https://www.wikipathways.org/index.php/Pathway:WP4191
446568ca-ab1d-55fd-9159-f0b5c500d98e,CAMKK2  Pathway WP4874,CAMKK2  Pathway,WP4874,https://www.wikipathways.org/index.php/Pathway:WP4874
9186c517-2c0f-5b52-8adf-50d447459dd2,Cancer immunotherapy by CTLA4 blockade WP4582,Cancer immunotherapy by CTLA4 blockade,WP4582,https://www.wikipathways.org/index.php/Pathway:WP4582
a5146cb6-d8e9-588e-ae79-788ea0482a46,Cancer immunotherapy by PD-1 blockade WP4585,Cancer immunotherapy by PD-1 blockade,WP4585,https://www.wikipathways.org/index.php/Pathway:WP4585
7291643d-18c8-563d-90af-0bde188a20a1,Cannabinoid receptor signaling WP3869,Cannabinoid receptor signaling,WP3869,https://www.wikipathways.org/index.php/Pathway:WP3869
ce0ab6bf-972c-5d48-b948-acd25e4b2df5,Canonical and non-canonical Notch signaling WP3845,Canonical and non-canonical Notch signaling,WP3845,https://www.wikipathways.org/index.php/Pathway:WP3845
d8cd5b74-00b9-5ff6-a490-fd5b21aed7b9,Canonical and non-canonical TGF-B signaling WP3874,Canonical and non-canonical TGF-B signaling,WP3874,https://www.wikipathways.org/index.php/Pathway:WP3874
3e6944ab-b352-5cf4-98c6-203d5a7a444e,Canonical NF-KB pathway WP4562,Canonical NF-KB pathway,WP4562,https://www.wikipathways.org/index.php/Pathway:WP4562
ab642a5c-d81e-5621-bdb6-3890018eed14,Cardiac Hypertrophic Response WP2795,Cardiac Hypertrophic Response,WP2795,https://www.wikipathways.org/index.php/Pathway:WP2795
fbe1655e-a4c6-5e79-8833-200a97e370ab,Cardiac Progenitor Differentiation WP2406,Cardiac Progenitor Differentiation,WP2406,https://www.wikipathways.org/index.php/Pathway:WP2406
c8f76586-ae95-5a9a-8502-4d21e525f5fb,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs),WP688,https://www.wikipathways.org/index.php/Pathway:WP688
0bec922b-2471-58ce-bc80-13258609a666,Cell cycle WP179,Cell cycle,WP179,https://www.wikipathways.org/index.php/Pathway:WP179
21226e25-df3e-5be6-84e7-4942aaa82b97,Cell Differentiation - Index expanded WP2023,Cell Differentiation - Index expanded,WP2023,https://www.wikipathways.org/index.php/Pathway:WP2023
f763bd7b-90e0-581d-9b4f-4338ddb8d81c,Cell Differentiation - Index WP2029,Cell Differentiation - Index,WP2029,https://www.wikipathways.org/index.php/Pathway:WP2029
4e6e7f12-4435-55ff-9a92-f56e2c2f9f2b,Cell migration and invasion through p75NTR WP4561,Cell migration and invasion through p75NTR,WP4561,https://www.wikipathways.org/index.php/Pathway:WP4561
8fa54fe8-e087-571d-ba9e-f514c7d1af00,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,Cell-type Dependent Selectivity of CCK2R Signaling,WP3679,https://www.wikipathways.org/index.php/Pathway:WP3679
bba79c27-5560-568e-807f-33455cabbdfe,Cells and molecules involved in local acute inflammatory response  WP4493,Cells and molecules involved in local acute inflammatory response ,WP4493,https://www.wikipathways.org/index.php/Pathway:WP4493
29760511-2e7f-5ad9-9d8d-6b1706a2f5bf,Cellular Proteostasis WP4918,Cellular Proteostasis,WP4918,https://www.wikipathways.org/index.php/Pathway:WP4918
cedcf4ae-54c7-5887-b6ce-035103e05e8e,"Cerebral organic acidurias, including diseases WP4519","Cerebral organic acidurias, including diseases",WP4519,https://www.wikipathways.org/index.php/Pathway:WP4519
138313cc-4702-51e0-8665-52cf33e6b6bf,Chemokine signaling pathway WP3929,Chemokine signaling pathway,WP3929,https://www.wikipathways.org/index.php/Pathway:WP3929
19e82b77-b9b8-5096-8d89-54ffae45bf44,Cholesterol Biosynthesis Pathway WP197,Cholesterol Biosynthesis Pathway,WP197,https://www.wikipathways.org/index.php/Pathway:WP197
b1d3e176-f67b-5233-87ce-81f4f5fb9daa,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,Cholesterol Biosynthesis with Skeletal Dysplasias,WP4804,https://www.wikipathways.org/index.php/Pathway:WP4804
b9324e48-b2a8-5524-a849-9ed4ab035dbd,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways),WP4718,https://www.wikipathways.org/index.php/Pathway:WP4718
c0b2d2e1-4038-523d-8a18-b1af4e688c2b,Chromosomal and microsatellite instability in colorectal cancer  WP4216,Chromosomal and microsatellite instability in colorectal cancer ,WP4216,https://www.wikipathways.org/index.php/Pathway:WP4216
d508a6c9-aa6b-5c2a-94fc-d316ae67eb20,Ciliary landscape WP4352,Ciliary landscape,WP4352,https://www.wikipathways.org/index.php/Pathway:WP4352
9dbbe6cd-f33e-5afe-ab07-830cc2aadd0d,Ciliopathies WP4803,Ciliopathies,WP4803,https://www.wikipathways.org/index.php/Pathway:WP4803
ed5da2c6-0469-5ef1-bcd1-1eefd2c475dc,Circadian rhythm related genes WP3594,Circadian rhythm related genes,WP3594,https://www.wikipathways.org/index.php/Pathway:WP3594
6577d3c7-0f04-574c-a571-8a5180114446,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism,WP4523,https://www.wikipathways.org/index.php/Pathway:WP4523
4f88e2b7-c8f1-5b33-bfa3-7a6cdfa38097,Codeine and Morphine Metabolism WP1604,Codeine and Morphine Metabolism,WP1604,https://www.wikipathways.org/index.php/Pathway:WP1604
39a98159-ab17-58e3-b851-9419aa7da4f8,Common Pathways Underlying Drug Addiction WP2636,Common Pathways Underlying Drug Addiction,WP2636,https://www.wikipathways.org/index.php/Pathway:WP2636
6943faf2-fb9d-56a5-a17d-27a2a113ef76,Complement Activation WP545,Complement Activation,WP545,https://www.wikipathways.org/index.php/Pathway:WP545
bd71b330-1045-50b5-9a2f-bb89b3e4e658,Complement and Coagulation Cascades WP558,Complement and Coagulation Cascades,WP558,https://www.wikipathways.org/index.php/Pathway:WP558
dfa0acd5-38b2-5b88-b8ce-7f02213d1368,Complement system WP2806,Complement system,WP2806,https://www.wikipathways.org/index.php/Pathway:WP2806
6be11cfa-e2a6-5711-a692-957ba886b710,Composition of Lipid Particles WP3601,Composition of Lipid Particles,WP3601,https://www.wikipathways.org/index.php/Pathway:WP3601
cfbfdf68-71e5-5024-9c28-1cd60b29a66a,Computational Model of Aerobic Glycolysis WP4629,Computational Model of Aerobic Glycolysis,WP4629,https://www.wikipathways.org/index.php/Pathway:WP4629
517f028c-508b-544e-9d06-6a25a8ef3584,Constitutive Androstane Receptor Pathway WP2875,Constitutive Androstane Receptor Pathway,WP2875,https://www.wikipathways.org/index.php/Pathway:WP2875
c538d6e8-8873-5273-9626-cce62e52ed7e,Control of immune tolerance by vasoactive intestinal peptide WP4484,Control of immune tolerance by vasoactive intestinal peptide,WP4484,https://www.wikipathways.org/index.php/Pathway:WP4484
092cd37d-b72a-571e-ad11-0062c2613408,Copper homeostasis WP3286,Copper homeostasis,WP3286,https://www.wikipathways.org/index.php/Pathway:WP3286
d0db645a-e692-5d06-a91a-df2fe9f2ede4,Cori Cycle WP1946,Cori Cycle,WP1946,https://www.wikipathways.org/index.php/Pathway:WP1946
73031d7e-e2eb-53e0-aa2f-1cf93f522522,Corticotropin-releasing hormone signaling pathway WP2355,Corticotropin-releasing hormone signaling pathway,WP2355,https://www.wikipathways.org/index.php/Pathway:WP2355
9297b051-2d15-50fe-8463-89cbf48d2eb1,COVID-19 adverse outcome pathway WP4891,COVID-19 adverse outcome pathway,WP4891,https://www.wikipathways.org/index.php/Pathway:WP4891
2e41321c-92ef-5a0a-b0ea-ace7fd18106b,"COVID-19, thrombosis and anticoagulation WP4927","COVID-19, thrombosis and anticoagulation",WP4927,https://www.wikipathways.org/index.php/Pathway:WP4927
2f845c54-6c1b-5a53-a2c8-82c51cc94d29,Cysteine and methionine catabolism WP4504,Cysteine and methionine catabolism,WP4504,https://www.wikipathways.org/index.php/Pathway:WP4504
f118c1d2-6506-5774-bc79-b9a5edfd69d0,Cytokines and Inflammatory Response WP530,Cytokines and Inflammatory Response,WP530,https://www.wikipathways.org/index.php/Pathway:WP530
a6c2f0bf-d491-5422-b6ed-0e197df4aa48,Cytoplasmic Ribosomal Proteins WP477,Cytoplasmic Ribosomal Proteins,WP477,https://www.wikipathways.org/index.php/Pathway:WP477
2332aa10-070f-5d3f-ac95-bf7ff3e774e7,Cytosine methylation WP3585,Cytosine methylation,WP3585,https://www.wikipathways.org/index.php/Pathway:WP3585
b6924193-8858-53b0-a32b-f5a7d3d7de0e,Cytosolic DNA-sensing pathway WP4655,Cytosolic DNA-sensing pathway,WP4655,https://www.wikipathways.org/index.php/Pathway:WP4655
770bc65a-8d4f-5716-8922-d80f1007bc39,DDX1 as a regulatory component of the Drosha microprocessor WP2942,DDX1 as a regulatory component of the Drosha microprocessor,WP2942,https://www.wikipathways.org/index.php/Pathway:WP2942
5a26f767-73b7-53ce-ae03-1665511bc762,"Degradation pathway of sphingolipids, including diseases WP4153","Degradation pathway of sphingolipids, including diseases",WP4153,https://www.wikipathways.org/index.php/Pathway:WP4153
5254dd80-6a17-57d9-95da-92878ba304d7,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,Deregulation of Rab and Rab Effector Genes in Bladder Cancer,WP2291,https://www.wikipathways.org/index.php/Pathway:WP2291
85917018-d30c-5ecf-beb3-dffeff396996,Development and heterogeneity of the ILC family WP3893,Development and heterogeneity of the ILC family,WP3893,https://www.wikipathways.org/index.php/Pathway:WP3893
062b9b1d-514e-50a8-90e8-2ccddd9b0c0c,Development of pulmonary dendritic cells and macrophage subsets WP3892,Development of pulmonary dendritic cells and macrophage subsets,WP3892,https://www.wikipathways.org/index.php/Pathway:WP3892
94fabd69-7f85-51de-9633-8592101b7ddc,Development of ureteric collection system WP5053,Development of ureteric collection system,WP5053,https://www.wikipathways.org/index.php/Pathway:WP5053
0c92f68e-1827-5d9e-89c8-060181b1e792,Differentiation of white and brown adipocyte WP2895,Differentiation of white and brown adipocyte,WP2895,https://www.wikipathways.org/index.php/Pathway:WP2895
e3f88dfa-fe56-5a39-bc5d-448f0c968def,Differentiation Pathway WP2848,Differentiation Pathway,WP2848,https://www.wikipathways.org/index.php/Pathway:WP2848
adc3ae93-de88-509b-ac43-d374fa45c9f7,Disorders of Folate Metabolism and Transport WP4259,Disorders of Folate Metabolism and Transport,WP4259,https://www.wikipathways.org/index.php/Pathway:WP4259
34266321-9810-50d1-8593-4e1c7a5b05d2,Disorders of the Krebs cycle WP4236,Disorders of the Krebs cycle,WP4236,https://www.wikipathways.org/index.php/Pathway:WP4236
21accb0e-da9d-5d01-b544-72414d8284a7,Disruption of postsynaptic signaling by CNV WP4875,Disruption of postsynaptic signaling by CNV,WP4875,https://www.wikipathways.org/index.php/Pathway:WP4875
66124844-57cc-55d9-b556-56053339e671,DNA damage response (only ATM dependent) WP710,DNA damage response (only ATM dependent),WP710,https://www.wikipathways.org/index.php/Pathway:WP710
e3b9fea1-2cb4-54e7-9595-f6d5e3933325,DNA damage response WP707,DNA damage response,WP707,https://www.wikipathways.org/index.php/Pathway:WP707
3859f63d-c015-5a07-9b3e-968c0946212b,DNA IR-damage and cellular response via ATR WP4016,DNA IR-damage and cellular response via ATR,WP4016,https://www.wikipathways.org/index.php/Pathway:WP4016
585bc255-091f-5f40-bc53-4e88ff71d917,DNA IR-double strand breaks and cellular response via ATM WP3959,DNA IR-double strand breaks and cellular response via ATM,WP3959,https://www.wikipathways.org/index.php/Pathway:WP3959
9f156a3f-d124-56ec-bb08-1121cb5c1770,DNA Mismatch Repair WP531,DNA Mismatch Repair,WP531,https://www.wikipathways.org/index.php/Pathway:WP531
44c41438-8ca3-5213-8452-babb72b6e06c,DNA Repair Pathways Full Network WP4946,DNA Repair Pathways Full Network,WP4946,https://www.wikipathways.org/index.php/Pathway:WP4946
2584caf7-5b25-563a-a943-1ef8a02f6f91,DNA Replication WP466,DNA Replication,WP466,https://www.wikipathways.org/index.php/Pathway:WP466
6535fda9-4e89-5698-94f5-562b0ab2cd42,Dopamine metabolism WP2436,Dopamine metabolism,WP2436,https://www.wikipathways.org/index.php/Pathway:WP2436
8acc810c-240e-5c4b-82f0-508c248cd149,Dopaminergic Neurogenesis WP2855,Dopaminergic Neurogenesis,WP2855,https://www.wikipathways.org/index.php/Pathway:WP2855
393d465c-0582-581b-8a19-c38ec99e781b,Drug Induction of Bile Acid Pathway WP2289,Drug Induction of Bile Acid Pathway,WP2289,https://www.wikipathways.org/index.php/Pathway:WP2289
519c2bda-84d1-53f6-b010-d8eb757b2a42,Dual hijack model of Vif in HIV infection WP3300,Dual hijack model of Vif in HIV infection,WP3300,https://www.wikipathways.org/index.php/Pathway:WP3300
9cef2941-df5e-5a79-8ebc-8625f76e0cb7,Ebola Virus Pathway on Host WP4217,Ebola Virus Pathway on Host,WP4217,https://www.wikipathways.org/index.php/Pathway:WP4217
a121f144-49b7-5207-92da-0b1f678d6b86,Ebstein-Barr virus LMP1 signaling WP262,Ebstein-Barr virus LMP1 signaling,WP262,https://www.wikipathways.org/index.php/Pathway:WP262
d28cb438-5580-54a2-94ea-10c56c0e66a0,Ectoderm Differentiation WP2858,Ectoderm Differentiation,WP2858,https://www.wikipathways.org/index.php/Pathway:WP2858
89ebfa0d-894f-5494-b00e-e0144445c8ac,EDA signaling in hair follicle development WP3930,EDA signaling in hair follicle development,WP3930,https://www.wikipathways.org/index.php/Pathway:WP3930
7a132e2c-f8c8-52d9-bb4c-93d2016042ae,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,WP4320,https://www.wikipathways.org/index.php/Pathway:WP4320
1cf65f30-d4ac-56b7-a499-7d4cbf351908,Effects of nitric oxide WP1995,Effects of nitric oxide,WP1995,https://www.wikipathways.org/index.php/Pathway:WP1995
ff5029d2-3859-5fca-8b07-596616cf1b29,EGF/EGFR signaling pathway WP437,EGF/EGFR signaling pathway,WP437,https://www.wikipathways.org/index.php/Pathway:WP437
46c5e31c-4633-5925-bd25-fb6090f362cc,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,EGFR Tyrosine Kinase Inhibitor Resistance,WP4806,https://www.wikipathways.org/index.php/Pathway:WP4806
7e270d1b-346e-572a-b5f2-bf9f224294e4,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,Eicosanoid metabolism via cyclooxygenases (COX),WP4719,https://www.wikipathways.org/index.php/Pathway:WP4719
759259ef-771b-55be-8c80-fddf6b882ab7,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway,WP4720,https://www.wikipathways.org/index.php/Pathway:WP4720
cccf5dc0-8e32-5e42-8877-43b069c180c7,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,Eicosanoid metabolism via lipooxygenases (LOX),WP4721,https://www.wikipathways.org/index.php/Pathway:WP4721
6ae847a6-c052-5a2b-9646-008bbcb9cb5b,Eicosanoid Synthesis WP167,Eicosanoid Synthesis,WP167,https://www.wikipathways.org/index.php/Pathway:WP167
ee24c39d-561c-5826-870c-d88494c2c601,Electron Transport Chain (OXPHOS system in mitochondria) WP111,Electron Transport Chain (OXPHOS system in mitochondria),WP111,https://www.wikipathways.org/index.php/Pathway:WP111
0a213cff-1525-5bcd-9627-ef27be1b5c27,Endochondral Ossification with Skeletal Dysplasias WP4808,Endochondral Ossification with Skeletal Dysplasias,WP4808,https://www.wikipathways.org/index.php/Pathway:WP4808
fdb63a06-d961-5ab8-80a5-ae65b0a471aa,Endochondral Ossification WP474,Endochondral Ossification,WP474,https://www.wikipathways.org/index.php/Pathway:WP474
3ee85139-6861-5a44-bfa6-72e00615e59c,Endoderm differentiation WP2853,Endoderm differentiation,WP2853,https://www.wikipathways.org/index.php/Pathway:WP2853
e67ba6d3-0dfb-5f63-99ca-987c8c48c3ff,Endometrial cancer WP4155,Endometrial cancer,WP4155,https://www.wikipathways.org/index.php/Pathway:WP4155
fc15f61c-02b8-5a42-8bcd-bd3ae5f38ac4,Endoplasmic reticulum stress response in coronavirus infection WP4861,Endoplasmic reticulum stress response in coronavirus infection,WP4861,https://www.wikipathways.org/index.php/Pathway:WP4861
dbb62bca-0c78-5fbd-aa4f-c09271e17544,Endothelin Pathways WP2197,Endothelin Pathways,WP2197,https://www.wikipathways.org/index.php/Pathway:WP2197
d7938a11-b6d9-565c-89be-fe35d6452bcd,Energy Metabolism WP1541,Energy Metabolism,WP1541,https://www.wikipathways.org/index.php/Pathway:WP1541
2df8efdb-b251-5ca2-8893-d31b3c83a843,Envelope proteins and their potential roles in EDMD physiopathology WP4535,Envelope proteins and their potential roles in EDMD physiopathology,WP4535,https://www.wikipathways.org/index.php/Pathway:WP4535
d6c9451e-3703-5eb9-9bcd-2466c64e0060,Epithelial to mesenchymal transition in colorectal cancer WP4239,Epithelial to mesenchymal transition in colorectal cancer,WP4239,https://www.wikipathways.org/index.php/Pathway:WP4239
e593bbe9-3742-59c9-b429-c6ed67c6d4e1,EPO Receptor Signaling WP581,EPO Receptor Signaling,WP581,https://www.wikipathways.org/index.php/Pathway:WP581
d94d4bd3-1ede-5da9-8e7a-4660deb207f1,ErbB signaling pathway WP673,ErbB signaling pathway,WP673,https://www.wikipathways.org/index.php/Pathway:WP673
860603c8-49fb-58d9-b1c4-1bec3af38628,ERK Pathway in Huntington's Disease WP3853,ERK Pathway in Huntington's Disease,WP3853,https://www.wikipathways.org/index.php/Pathway:WP3853
7dbca2bf-4e99-5982-a51a-ff62d62c2d88,ESC Pluripotency Pathways WP3931,ESC Pluripotency Pathways,WP3931,https://www.wikipathways.org/index.php/Pathway:WP3931
4c9c01bf-ae0f-5a1f-a699-efa7d747200c,Estrogen metabolism WP697,Estrogen metabolism,WP697,https://www.wikipathways.org/index.php/Pathway:WP697
fe9387c6-2554-525c-92b5-c32d09a54d88,Estrogen Receptor Pathway WP2881,Estrogen Receptor Pathway,WP2881,https://www.wikipathways.org/index.php/Pathway:WP2881
4cb753d4-b17e-5cc3-81e5-c4695df058ef,Estrogen signaling pathway WP712,Estrogen signaling pathway,WP712,https://www.wikipathways.org/index.php/Pathway:WP712
20e69e63-a0e9-5f91-a9e0-49374a2583a5,Ethanol effects on histone modifications WP3996,Ethanol effects on histone modifications,WP3996,https://www.wikipathways.org/index.php/Pathway:WP3996
9585495a-c623-56cd-a598-79225349d765,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,Ethanol metabolism resulting in production of ROS by CYP2E1,WP4269,https://www.wikipathways.org/index.php/Pathway:WP4269
50146e93-c438-5c2b-ad12-d98a45281119,Eukaryotic Transcription Initiation WP405,Eukaryotic Transcription Initiation,WP405,https://www.wikipathways.org/index.php/Pathway:WP405
14f9e2fd-644f-52af-a91b-fce474abc593,EV release from cardiac cells and their functional effects WP3297,EV release from cardiac cells and their functional effects,WP3297,https://www.wikipathways.org/index.php/Pathway:WP3297
f6d57634-b5a2-555e-a89c-8a5d5561e21c,Exercise-induced Circadian Regulation WP410,Exercise-induced Circadian Regulation,WP410,https://www.wikipathways.org/index.php/Pathway:WP410
03299a0e-1521-5590-9e66-fccc982a4ea3,exRNA mechanism of action and biogenesis WP2805,exRNA mechanism of action and biogenesis,WP2805,https://www.wikipathways.org/index.php/Pathway:WP2805
35e27bf2-1ff4-5360-b70c-ae526c3f93c8,Extracellular vesicle-mediated signaling in recipient cells WP2870,Extracellular vesicle-mediated signaling in recipient cells,WP2870,https://www.wikipathways.org/index.php/Pathway:WP2870
38466e1e-214e-5726-b220-5668763167ca,Extracellular vesicles in the crosstalk of cardiac cells WP4300,Extracellular vesicles in the crosstalk of cardiac cells,WP4300,https://www.wikipathways.org/index.php/Pathway:WP4300
7c2455f8-ad20-5380-9eeb-7a304143d0d2,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling,WP3850,https://www.wikipathways.org/index.php/Pathway:WP3850
a2e58777-bfb4-5a7f-a4f7-4f3a41ba54b4,Farnesoid X receptor pathway WP2879,Farnesoid X receptor pathway,WP2879,https://www.wikipathways.org/index.php/Pathway:WP2879
efae001f-d4d1-5f0b-a604-5cc298cbbd5d,Fas ligand pathway and stress induction of heat shock proteins WP314,Fas ligand pathway and stress induction of heat shock proteins,WP314,https://www.wikipathways.org/index.php/Pathway:WP314
4992f4ed-cca5-5fa9-b620-5e00a9a0fdf6,Fatty acid beta-oxidation WP143,Fatty acid beta-oxidation,WP143,https://www.wikipathways.org/index.php/Pathway:WP143
67d34bab-9d0c-59e3-8fa8-776af0ee6a2c,Fatty Acid Biosynthesis WP357,Fatty Acid Biosynthesis,WP357,https://www.wikipathways.org/index.php/Pathway:WP357
d1c5225c-0a9d-5bcd-b152-299910b6306a,Fatty Acid Omega Oxidation WP206,Fatty Acid Omega Oxidation,WP206,https://www.wikipathways.org/index.php/Pathway:WP206
53451fb0-9cbf-5131-9c86-b1e309b978c9,Fatty acid transporters WP5061,Fatty acid transporters,WP5061,https://www.wikipathways.org/index.php/Pathway:WP5061
fc15f4ff-cc82-59b2-b842-8f0acf7013c5,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,WP4553,https://www.wikipathways.org/index.php/Pathway:WP4553
5a65ee85-9832-5c6e-a88f-f1a45aec00fb,Ferroptosis WP4313,Ferroptosis,WP4313,https://www.wikipathways.org/index.php/Pathway:WP4313
cdd7880a-4eec-56fd-ba06-369586c7cbe3,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,FGF23 signaling in hypophosphatemic rickets and related disorders,WP4790,https://www.wikipathways.org/index.php/Pathway:WP4790
db850eb2-1c6d-5c4f-ae8d-1a1d7520a307,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,FGFR3 signaling in chondrocyte proliferation and terminal differentiation,WP4767,https://www.wikipathways.org/index.php/Pathway:WP4767
abc1abc1-3a60-569c-a581-75c52380a48e,Fibrin Complement Receptor 3 Signaling Pathway WP4136,Fibrin Complement Receptor 3 Signaling Pathway,WP4136,https://www.wikipathways.org/index.php/Pathway:WP4136
71c992e9-f6b6-5dd8-a7bc-de129dd2736c,Fluoroacetic acid toxicity WP4966,Fluoroacetic acid toxicity,WP4966,https://www.wikipathways.org/index.php/Pathway:WP4966
57d25466-b687-5234-acc2-c0e19e723dde,Fluoropyrimidine Activity WP1601,Fluoropyrimidine Activity,WP1601,https://www.wikipathways.org/index.php/Pathway:WP1601
ed21e5e8-c342-5a65-98b4-84c6ae0a8178,Focal Adhesion WP306,Focal Adhesion,WP306,https://www.wikipathways.org/index.php/Pathway:WP306
91cb1abe-a2ac-5277-be84-9ca35001ee7d,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,WP3932,https://www.wikipathways.org/index.php/Pathway:WP3932
c51b1b29-33ea-5e09-bc22-5f807d5f626c,Folate Metabolism WP176,Folate Metabolism,WP176,https://www.wikipathways.org/index.php/Pathway:WP176
5a606a1c-d23b-5317-88b7-6be867e7ed3b,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,Folate-Alcohol and Cancer Pathway Hypotheses,WP1589,https://www.wikipathways.org/index.php/Pathway:WP1589
d1c2978f-7de2-5f7c-8785-35e2089d40d5,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,Follicle Stimulating Hormone (FSH) signaling pathway,WP2035,https://www.wikipathways.org/index.php/Pathway:WP2035
671b3397-3c94-5e62-a98d-e43df4bc8b12,FOXA2 pathway WP5066,FOXA2 pathway,WP5066,https://www.wikipathways.org/index.php/Pathway:WP5066
29637ae5-a5cc-5991-8908-19491a3d7c35,FOXP3 in COVID-19 WP5063,FOXP3 in COVID-19,WP5063,https://www.wikipathways.org/index.php/Pathway:WP5063
b0116488-af36-5b12-8091-be44a4ff6d87,Fragile X Syndrome  WP4549,Fragile X Syndrome ,WP4549,https://www.wikipathways.org/index.php/Pathway:WP4549
045a79a8-fb2e-500f-92cf-98f279c96c5a,FTO Obesity Variant Mechanism WP3407,FTO Obesity Variant Mechanism,WP3407,https://www.wikipathways.org/index.php/Pathway:WP3407
df88cfcd-d184-5c3d-b641-6b1fe083a975,G Protein Signaling Pathways WP35,G Protein Signaling Pathways,WP35,https://www.wikipathways.org/index.php/Pathway:WP35
39465791-753b-5c5f-af00-1e80247d65c7,G1 to S cell cycle control WP45,G1 to S cell cycle control,WP45,https://www.wikipathways.org/index.php/Pathway:WP45
e2ef9e24-3d43-5780-b844-23c08a05d754,G13 Signaling Pathway WP524,G13 Signaling Pathway,WP524,https://www.wikipathways.org/index.php/Pathway:WP524
0eac5239-9f90-5a37-9e04-98cca93cd1a3,GABA metabolism (aka GHB) WP4157,GABA metabolism (aka GHB),WP4157,https://www.wikipathways.org/index.php/Pathway:WP4157
bade9b39-df9f-578e-bfd2-1dd15df2286c,GABA receptor Signaling WP4159,GABA receptor Signaling,WP4159,https://www.wikipathways.org/index.php/Pathway:WP4159
b9c26c0a-eec2-5ce2-9dd6-37908a77d054,Galanin receptor pathway WP4970,Galanin receptor pathway,WP4970,https://www.wikipathways.org/index.php/Pathway:WP4970
0835d683-3744-528a-b4d8-6a4b7bcdfbbe,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518","Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases",WP4518,https://www.wikipathways.org/index.php/Pathway:WP4518
9d3bbf86-a2ff-5293-ba8d-24ef44ddd1d0,Ganglio Sphingolipid Metabolism WP1423,Ganglio Sphingolipid Metabolism,WP1423,https://www.wikipathways.org/index.php/Pathway:WP1423
7326d0d0-8d46-53f4-9a51-cb83191b025c,Gastric acid production WP2596,Gastric acid production,WP2596,https://www.wikipathways.org/index.php/Pathway:WP2596
929decd8-9e92-5a39-9bdf-9e20c2725018,Gastric Cancer Network 1 WP2361,Gastric Cancer Network 1,WP2361,https://www.wikipathways.org/index.php/Pathway:WP2361
760d879f-f8fe-5d85-8898-4dd1098c358f,Gastric Cancer Network 2 WP2363,Gastric Cancer Network 2,WP2363,https://www.wikipathways.org/index.php/Pathway:WP2363
7720e852-6b66-5382-98c9-616393a41cf4,Gastrin signaling pathway WP4659,Gastrin signaling pathway,WP4659,https://www.wikipathways.org/index.php/Pathway:WP4659
22a7beb4-d766-500a-add2-f6498ab36dbd,GDNF/RET signaling axis WP4830,GDNF/RET signaling axis,WP4830,https://www.wikipathways.org/index.php/Pathway:WP4830
40798355-357d-54ac-8199-7a1868b4fd0a,Gene regulatory network modelling somitogenesis  WP2854,Gene regulatory network modelling somitogenesis ,WP2854,https://www.wikipathways.org/index.php/Pathway:WP2854
89fe855c-6841-50bc-a7d7-6e4c0428b325,Genes controlling nephrogenesis WP4823,Genes controlling nephrogenesis,WP4823,https://www.wikipathways.org/index.php/Pathway:WP4823
0539c834-3065-55cc-85fb-655f40c3262a,Genes related to primary cilium development (based on CRISPR) WP4536,Genes related to primary cilium development (based on CRISPR),WP4536,https://www.wikipathways.org/index.php/Pathway:WP4536
958b822e-2e14-55f0-8077-a683913cc33b,Genes targeted by miRNAs in adipocytes WP1992,Genes targeted by miRNAs in adipocytes,WP1992,https://www.wikipathways.org/index.php/Pathway:WP1992
644d6784-9e82-5565-9344-0d6498e4d310,Genotoxicity pathway WP4286,Genotoxicity pathway,WP4286,https://www.wikipathways.org/index.php/Pathway:WP4286
49f39f50-8fc0-5844-816c-dc622ca24fd0,Glial Cell Differentiation WP2276,Glial Cell Differentiation,WP2276,https://www.wikipathways.org/index.php/Pathway:WP2276
954c315b-1201-5728-a0ba-42a69cf1818c,Glioblastoma signaling pathways WP2261,Glioblastoma signaling pathways,WP2261,https://www.wikipathways.org/index.php/Pathway:WP2261
7f64b067-01bd-5d28-a699-3287fd548724,Globo Sphingolipid Metabolism WP1424,Globo Sphingolipid Metabolism,WP1424,https://www.wikipathways.org/index.php/Pathway:WP1424
e29b5241-d166-5e37-847f-647357456ad0,Glucocorticoid Receptor Pathway WP2880,Glucocorticoid Receptor Pathway,WP2880,https://www.wikipathways.org/index.php/Pathway:WP2880
2f91e86c-d6bd-58f1-b1d1-e20f41aba03f,Glucuronidation WP698,Glucuronidation,WP698,https://www.wikipathways.org/index.php/Pathway:WP698
0a210010-cb4e-54dd-8ad2-95a289958316,Glutathione metabolism WP100,Glutathione metabolism,WP100,https://www.wikipathways.org/index.php/Pathway:WP100
57c659cb-38a0-5d1b-8fc9-a21fd5b54810,Glycerolipids and Glycerophospholipids WP4722,Glycerolipids and Glycerophospholipids,WP4722,https://www.wikipathways.org/index.php/Pathway:WP4722
f98a9e54-2cbb-518f-8788-800f7d6aa26e,Glycerophospholipid Biosynthetic Pathway WP2533,Glycerophospholipid Biosynthetic Pathway,WP2533,https://www.wikipathways.org/index.php/Pathway:WP2533
55f71c41-9ea8-5cdc-af01-059492a70a83,Glycogen Synthesis and Degradation WP500,Glycogen Synthesis and Degradation,WP500,https://www.wikipathways.org/index.php/Pathway:WP500
0f66098c-698f-53fe-923a-80f8c26773c4,Glycolysis and Gluconeogenesis WP534,Glycolysis and Gluconeogenesis,WP534,https://www.wikipathways.org/index.php/Pathway:WP534
164089de-35a3-5d91-9258-266c350761a2,Glycolysis in senescence WP5049,Glycolysis in senescence,WP5049,https://www.wikipathways.org/index.php/Pathway:WP5049
e1358a0c-390c-59a2-8e05-1f87fef90bfc,Glycosaminoglycan degradation WP4815,Glycosaminoglycan degradation,WP4815,https://www.wikipathways.org/index.php/Pathway:WP4815
01a75338-914c-58ad-aa25-e787eed1c08f,Glycosylation and related congenital defects WP4521,Glycosylation and related congenital defects,WP4521,https://www.wikipathways.org/index.php/Pathway:WP4521
cc143e40-02de-562e-9a2a-23317ec3e172,"GPCRs, Class A Rhodopsin-like WP455","GPCRs, Class A Rhodopsin-like",WP455,https://www.wikipathways.org/index.php/Pathway:WP455
fbe263e7-2a29-587c-b6ad-6603f36e121c,"GPCRs, Class B Secretin-like WP334","GPCRs, Class B Secretin-like",WP334,https://www.wikipathways.org/index.php/Pathway:WP334
22108312-2f76-548d-a2dc-213419fe8781,"GPCRs, Class C Metabotropic glutamate, pheromone WP501","GPCRs, Class C Metabotropic glutamate, pheromone",WP501,https://www.wikipathways.org/index.php/Pathway:WP501
5f5d7116-4f11-5938-b494-9d7d5b5a1588,"GPCRs, Other WP117","GPCRs, Other",WP117,https://www.wikipathways.org/index.php/Pathway:WP117
64ebb3f7-b687-5fd1-a5f8-66079ae861fd,GPR40 Pathway WP3958,GPR40 Pathway,WP3958,https://www.wikipathways.org/index.php/Pathway:WP3958
f0d98d4c-d79f-5fd9-ac04-47c873010496,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,WP3969,https://www.wikipathways.org/index.php/Pathway:WP3969
ccf5e6da-6d8b-517e-b28c-3db3dce5ef51,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,Hair Follicle Development: Organogenesis - Part 2 of 3,WP2839,https://www.wikipathways.org/index.php/Pathway:WP2839
423cdfe0-4e9d-575e-9ee4-85f21fd29d19,Head and Neck Squamous Cell Carcinoma WP4674,Head and Neck Squamous Cell Carcinoma,WP4674,https://www.wikipathways.org/index.php/Pathway:WP4674
ed7ce7b1-3a3f-552e-a34f-05924981338f,Heart Development WP1591,Heart Development,WP1591,https://www.wikipathways.org/index.php/Pathway:WP1591
0e30fd97-58c9-5464-90ac-37ef01bea8ab,Hedgehog Signaling Pathway Netpath WP47,Hedgehog Signaling Pathway Netpath,WP47,https://www.wikipathways.org/index.php/Pathway:WP47
c83d2cc1-9401-5b01-b39b-51abafb74b0c,Hedgehog Signaling Pathway WP4249,Hedgehog Signaling Pathway,WP4249,https://www.wikipathways.org/index.php/Pathway:WP4249
16116a43-413a-5d32-b948-1e15eb4607c8,Hematopoietic Stem Cell Differentiation WP2849,Hematopoietic Stem Cell Differentiation,WP2849,https://www.wikipathways.org/index.php/Pathway:WP2849
74bddc24-bf43-5841-9dd1-f30bb89ea122,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex,WP3657,https://www.wikipathways.org/index.php/Pathway:WP3657
fa8acdcc-8220-545a-a84f-00a65d477fb1,Heme Biosynthesis WP561,Heme Biosynthesis,WP561,https://www.wikipathways.org/index.php/Pathway:WP561
ef3ba0fb-c332-5198-9724-a7271363e359,Hepatitis B infection WP4666,Hepatitis B infection,WP4666,https://www.wikipathways.org/index.php/Pathway:WP4666
54f53165-6057-5383-a387-2dbc3fb1852e,Hepatitis C and Hepatocellular Carcinoma WP3646,Hepatitis C and Hepatocellular Carcinoma,WP3646,https://www.wikipathways.org/index.php/Pathway:WP3646
fa1691c1-0a13-521c-8bd4-665178d869a9,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,Hereditary leiomyomatosis and renal cell carcinoma pathway,WP4206,https://www.wikipathways.org/index.php/Pathway:WP4206
fb6a73f2-e2ce-5a9e-a9e9-bc024236347c,Hfe effect on hepcidin production WP3924,Hfe effect on hepcidin production,WP3924,https://www.wikipathways.org/index.php/Pathway:WP3924
b48e641c-8beb-5b0f-b7ba-5b0d3541cf94,HIF1A and PPARG regulation of glycolysis WP2456,HIF1A and PPARG regulation of glycolysis,WP2456,https://www.wikipathways.org/index.php/Pathway:WP2456
a4225059-f1fa-5e9c-9eda-5844749b56f5,Hijack of ubiquitination by SARS-CoV-2 WP4860,Hijack of ubiquitination by SARS-CoV-2,WP4860,https://www.wikipathways.org/index.php/Pathway:WP4860
75a80017-9252-5662-aace-82c1c08a7769,Hippo-Merlin Signaling Dysregulation WP4541,Hippo-Merlin Signaling Dysregulation,WP4541,https://www.wikipathways.org/index.php/Pathway:WP4541
3a71a5bb-6206-50ae-be89-c351d73f1453,Hippo-Yap signaling pathway WP4537,Hippo-Yap signaling pathway,WP4537,https://www.wikipathways.org/index.php/Pathway:WP4537
0a0b4f9f-dab3-5b1b-972c-20be710a53da,Histone Modifications WP2369,Histone Modifications,WP2369,https://www.wikipathways.org/index.php/Pathway:WP2369
cf78e553-7dbf-5a8a-bfd6-694bfb763c79,Homologous recombination WP186,Homologous recombination,WP186,https://www.wikipathways.org/index.php/Pathway:WP186
5f44ffea-cc38-56a4-84bb-6ec79afe4cfe,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,Host-pathogen interaction of human coronaviruses - apoptosis,WP4864,https://www.wikipathways.org/index.php/Pathway:WP4864
f55781da-c770-5b9b-abcf-ec18fc1661ad,Host-pathogen interaction of human coronaviruses - autophagy WP4863,Host-pathogen interaction of human coronaviruses - autophagy,WP4863,https://www.wikipathways.org/index.php/Pathway:WP4863
b0a13220-2a28-5990-bf9e-d636a43d4e7e,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,Host-pathogen interaction of human coronaviruses - interferon induction,WP4880,https://www.wikipathways.org/index.php/Pathway:WP4880
7b45e9df-ad6d-5962-9230-c8bbe00d1eca,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,Host-pathogen interaction of human coronaviruses - MAPK signaling,WP4877,https://www.wikipathways.org/index.php/Pathway:WP4877
18a4b7c2-9e77-5870-af34-59f6959c6967,Hypertrophy Model WP516,Hypertrophy Model,WP516,https://www.wikipathways.org/index.php/Pathway:WP516
1aaac241-a7a4-55a5-8be2-04b9028c4dbe,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease,WP3668,https://www.wikipathways.org/index.php/Pathway:WP3668
831ceed1-c4d1-53f8-a6d9-3fe0be7256f6,Hypothetical Craniofacial Development Pathway WP3655,Hypothetical Craniofacial Development Pathway,WP3655,https://www.wikipathways.org/index.php/Pathway:WP3655
de5c5255-995b-5114-a760-71afe6ea228b,ID signaling pathway WP53,ID signaling pathway,WP53,https://www.wikipathways.org/index.php/Pathway:WP53
de87ed5c-4e14-596c-aa9e-bd4b4eb6d9f4,IL-1 signaling pathway WP195,IL-1 signaling pathway,WP195,https://www.wikipathways.org/index.php/Pathway:WP195
f4386c87-8b12-5feb-b27b-5e2d4c9f56f2,IL-10 Anti-inflammatory Signaling Pathway  WP4495,IL-10 Anti-inflammatory Signaling Pathway ,WP4495,https://www.wikipathways.org/index.php/Pathway:WP4495
21322227-4bc4-5cff-ba82-8edba10bcf3a,IL-18 signaling pathway WP4754,IL-18 signaling pathway,WP4754,https://www.wikipathways.org/index.php/Pathway:WP4754
19750b77-f4ba-5544-b089-54cbe5a9a5bf,IL-2 signaling pathway WP49,IL-2 signaling pathway,WP49,https://www.wikipathways.org/index.php/Pathway:WP49
52849455-8352-5b4f-9117-49cebcbb77b4,IL-3 signaling pathway WP286,IL-3 signaling pathway,WP286,https://www.wikipathways.org/index.php/Pathway:WP286
b24b379f-38bf-517b-90a2-6db4feb0c425,IL-4 signaling pathway WP395,IL-4 signaling pathway,WP395,https://www.wikipathways.org/index.php/Pathway:WP395
e9db5a4b-795a-51b5-a18d-a2358bee4e07,IL-5 signaling pathway WP127,IL-5 signaling pathway,WP127,https://www.wikipathways.org/index.php/Pathway:WP127
ec408805-eef6-573e-a752-29273b65f775,IL-6 signaling pathway WP364,IL-6 signaling pathway,WP364,https://www.wikipathways.org/index.php/Pathway:WP364
240f999c-7160-564f-b467-c929eedd3658,IL-7 signaling pathway WP205,IL-7 signaling pathway,WP205,https://www.wikipathways.org/index.php/Pathway:WP205
05abf156-1cf5-5bcf-93c7-bd19c8db97a0,IL-9 signaling pathway WP22,IL-9 signaling pathway,WP22,https://www.wikipathways.org/index.php/Pathway:WP22
b880c6d2-0632-5cc2-9d0c-55e99abdbfad,IL1 and megakaryocytes in obesity WP2865,IL1 and megakaryocytes in obesity,WP2865,https://www.wikipathways.org/index.php/Pathway:WP2865
c1c70b43-1df2-5e85-a0e2-2f9456d1eff2,IL17 signaling pathway WP2112,IL17 signaling pathway,WP2112,https://www.wikipathways.org/index.php/Pathway:WP2112
5733b12f-246b-5b0e-993a-ed2dadb4270e,Imatinib and Chronic Myeloid Leukemia WP3640,Imatinib and Chronic Myeloid Leukemia,WP3640,https://www.wikipathways.org/index.php/Pathway:WP3640
315266c5-2e05-5882-823f-543800d592c4,Immune response to tuberculosis WP4197,Immune response to tuberculosis,WP4197,https://www.wikipathways.org/index.php/Pathway:WP4197
fafb0640-b919-588d-ab45-5fd995fcb7de,Inflammatory Response Pathway WP453,Inflammatory Response Pathway,WP453,https://www.wikipathways.org/index.php/Pathway:WP453
100f648f-ac5d-5af7-acd5-14ac5bade4a2,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,WP4301,https://www.wikipathways.org/index.php/Pathway:WP4301
041ff273-c637-560f-8379-4c8bcc4f87a0,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,Initiation of transcription and translation elongation at the HIV-1 LTR,WP3414,https://www.wikipathways.org/index.php/Pathway:WP3414
72dc244c-0405-5735-92fd-bead9efa6cbe,Insulin signaling in adipocytes (diabetic condition) WP3635,Insulin signaling in adipocytes (diabetic condition),WP3635,https://www.wikipathways.org/index.php/Pathway:WP3635
26f33629-01a6-5a4e-adba-d252722b2ca1,Insulin signaling in adipocytes (normal condition) WP3634,Insulin signaling in adipocytes (normal condition),WP3634,https://www.wikipathways.org/index.php/Pathway:WP3634
17fb5af0-7960-58d6-b9aa-d36d8ce1b602,Insulin Signaling WP481,Insulin Signaling,WP481,https://www.wikipathways.org/index.php/Pathway:WP481
448613d5-0555-5b25-977f-7444f17a63c5,Integrated breast cancer pathway WP1984,Integrated breast cancer pathway,WP1984,https://www.wikipathways.org/index.php/Pathway:WP1984
8dbd48bd-afd9-5548-a378-c5c1f8e75837,Integrated Cancer Pathway WP1971,Integrated Cancer Pathway,WP1971,https://www.wikipathways.org/index.php/Pathway:WP1971
30119b36-2a6b-554d-81fc-ef0d2fcd2aa1,Integrin-mediated Cell Adhesion WP185,Integrin-mediated Cell Adhesion,WP185,https://www.wikipathways.org/index.php/Pathway:WP185
30e81e56-3d62-5a08-8e9e-664c5ea36f1e,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,Interactions between immune cells and microRNAs in tumor microenvironment,WP4559,https://www.wikipathways.org/index.php/Pathway:WP4559
15b42e63-6a25-5ebf-be4e-005b95f78255,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,Interactome of polycomb repressive complex 2 (PRC2) ,WP2916,https://www.wikipathways.org/index.php/Pathway:WP2916
d618c697-2fa3-570a-a8cf-429a9dbfa085,Interferon type I signaling pathways WP585,Interferon type I signaling pathways,WP585,https://www.wikipathways.org/index.php/Pathway:WP585
7d39d2ce-cc10-528e-9a3d-4ccd86bcda1a,Interleukin-1 Induced Activation of NF-kappa-B WP3656,Interleukin-1 Induced Activation of NF-kappa-B,WP3656,https://www.wikipathways.org/index.php/Pathway:WP3656
3870106c-c211-5c10-86a6-719d22ab2713,Interleukin-11 Signaling Pathway WP2332,Interleukin-11 Signaling Pathway,WP2332,https://www.wikipathways.org/index.php/Pathway:WP2332
d5ffca9e-bf82-5385-ba15-b4fa4302be8c,Intracellular trafficking proteins involved in CMT neuropathy WP4856,Intracellular trafficking proteins involved in CMT neuropathy,WP4856,https://www.wikipathways.org/index.php/Pathway:WP4856
292da531-de53-55a1-8986-0a6ad02422bf,Intraflagellar transport proteins binding to dynein WP4532,Intraflagellar transport proteins binding to dynein,WP4532,https://www.wikipathways.org/index.php/Pathway:WP4532
d6c4884d-35f4-50dd-bf19-73867b2e0513,Irinotecan pathway WP229,Irinotecan pathway,WP229,https://www.wikipathways.org/index.php/Pathway:WP229
cdec6636-70e3-5c1d-91b1-d1fd0e709b4a,Iron metabolism in placenta WP2007,Iron metabolism in placenta,WP2007,https://www.wikipathways.org/index.php/Pathway:WP2007
3d43826e-62df-5f23-98c6-d3a41b07b058,Joubert Syndrome WP4656,Joubert Syndrome,WP4656,https://www.wikipathways.org/index.php/Pathway:WP4656
57fd059c-aa73-55cf-8c55-b375904ed104,Kallmann's Syndrome WP5074,Kallmann's Syndrome,WP5074,https://www.wikipathways.org/index.php/Pathway:WP5074
a9fca4d7-d666-597e-b51b-dba02ac4b0d8,Kennedy pathway from sphingolipids WP3933,Kennedy pathway from sphingolipids,WP3933,https://www.wikipathways.org/index.php/Pathway:WP3933
a0731b5b-8887-55be-ae0a-c822b62989d7,Ketogenesis and Ketolysis WP4742,Ketogenesis and Ketolysis,WP4742,https://www.wikipathways.org/index.php/Pathway:WP4742
11dcf2c1-9bac-5acc-b0d2-4c098093320f,Kisspeptin/kisspeptin receptor system in the ovary WP4871,Kisspeptin/kisspeptin receptor system in the ovary,WP4871,https://www.wikipathways.org/index.php/Pathway:WP4871
d1d8d0ab-c955-5f37-a3bf-a9ac9bc098d8,Kit receptor signaling pathway WP304,Kit receptor signaling pathway,WP304,https://www.wikipathways.org/index.php/Pathway:WP304
fbb1edaa-5645-5060-b4b2-0301ac5a09b5,Kynurenine Pathway and links to Cellular Senescence WP5044,Kynurenine Pathway and links to Cellular Senescence,WP5044,https://www.wikipathways.org/index.php/Pathway:WP5044
e40909ff-ed83-5d06-a6d0-6e6d97b7d868,LDLRAD4 and what we know about it WP4904,LDLRAD4 and what we know about it,WP4904,https://www.wikipathways.org/index.php/Pathway:WP4904
95f78b86-cae5-5509-8234-f0086ef92d3e,Leptin and adiponectin WP3934,Leptin and adiponectin,WP3934,https://www.wikipathways.org/index.php/Pathway:WP3934
d864d01a-5be1-5469-8deb-aee077050fb1,Leptin Insulin Overlap WP3935,Leptin Insulin Overlap,WP3935,https://www.wikipathways.org/index.php/Pathway:WP3935
65db0969-af7f-56f3-827e-cb2a3ad683ae,Leptin signaling pathway WP2034,Leptin signaling pathway,WP2034,https://www.wikipathways.org/index.php/Pathway:WP2034
9776dc6e-d2f9-5650-a11b-2f7c6ed7cb84,let-7 inhibition of ES cell reprogramming WP3299,let-7 inhibition of ES cell reprogramming,WP3299,https://www.wikipathways.org/index.php/Pathway:WP3299
5d243d07-325d-5053-a4d4-456aa36a0bba,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,Linoleic acid metabolism known to be affected by coronavirus infection,WP4853,https://www.wikipathways.org/index.php/Pathway:WP4853
97122ccb-26d6-5b3f-9973-2afc5ed2ef35,Lipid Metabolism Pathway WP3965,Lipid Metabolism Pathway,WP3965,https://www.wikipathways.org/index.php/Pathway:WP3965
df0d6498-b713-546c-9a52-603452a68151,Liver X receptor pathway WP2874,Liver X receptor pathway,WP2874,https://www.wikipathways.org/index.php/Pathway:WP2874
4448b5cb-9918-572c-af1b-54f0289eb36d,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,LncRNA involvement in canonical Wnt signaling and colorectal cancer,WP4258,https://www.wikipathways.org/index.php/Pathway:WP4258
34ba2c9c-5327-5b02-b0b0-0486a67ecba1,LncRNA-mediated mechanisms of therapeutic resistance WP3672,LncRNA-mediated mechanisms of therapeutic resistance,WP3672,https://www.wikipathways.org/index.php/Pathway:WP3672
4c8588cd-afa6-546e-b726-9dbef2feb78b,LTF danger signal response pathway WP4478,LTF danger signal response pathway,WP4478,https://www.wikipathways.org/index.php/Pathway:WP4478
a2252a48-d762-5551-b7fc-fad76e32c968,Lung fibrosis WP3624,Lung fibrosis,WP3624,https://www.wikipathways.org/index.php/Pathway:WP3624
6e52dc07-1ca9-57fc-9dd7-292b34b30fa9,Macrophage markers WP4146,Macrophage markers,WP4146,https://www.wikipathways.org/index.php/Pathway:WP4146
624243fb-2a9b-5e9f-ab4b-794e145a0be5,Major receptors targeted by epinephrine and norepinephrine WP4589,Major receptors targeted by epinephrine and norepinephrine,WP4589,https://www.wikipathways.org/index.php/Pathway:WP4589
f184aacc-965a-50b4-8547-44636c793046,Male infertility WP4673,Male infertility,WP4673,https://www.wikipathways.org/index.php/Pathway:WP4673
15da86ec-78e3-5ba7-bdbe-554a814d242a,Mammalian disorder of sexual development WP4842,Mammalian disorder of sexual development,WP4842,https://www.wikipathways.org/index.php/Pathway:WP4842
d16d16b1-9742-5335-9e4f-7762dadb215c,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,Mammary gland development pathway - Embryonic development (Stage 1 of 4),WP2813,https://www.wikipathways.org/index.php/Pathway:WP2813
09bc3c64-2af7-5306-82b8-d47a10530d85,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,Mammary gland development pathway - Involution (Stage 4 of 4),WP2815,https://www.wikipathways.org/index.php/Pathway:WP2815
e68d3989-e737-51c8-a91f-6b94d924df0d,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),WP2817,https://www.wikipathways.org/index.php/Pathway:WP2817
ee36697e-4d81-5eb6-9fb3-b72984dd59ff,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,Mammary gland development pathway - Puberty (Stage 2 of 4),WP2814,https://www.wikipathways.org/index.php/Pathway:WP2814
039f21df-c1e4-564b-bbd1-d7265ab4c3b7,MAP3K1 role in promoting and blocking gonadal determination WP4872,MAP3K1 role in promoting and blocking gonadal determination,WP4872,https://www.wikipathways.org/index.php/Pathway:WP4872
c3f9b8a7-e324-526e-aa3d-84c644ea2262,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ,WP3849,https://www.wikipathways.org/index.php/Pathway:WP3849
8265803a-8be2-5603-8a76-538c3eddff59,MAPK Cascade WP422,MAPK Cascade,WP422,https://www.wikipathways.org/index.php/Pathway:WP422
dce018dc-80d2-529c-be66-ace3c0a0085c,MAPK pathway in congenital thyroid cancer WP4928,MAPK pathway in congenital thyroid cancer,WP4928,https://www.wikipathways.org/index.php/Pathway:WP4928
e046d740-6592-50d7-8394-1969bb84ff36,MAPK Signaling Pathway WP382,MAPK Signaling Pathway,WP382,https://www.wikipathways.org/index.php/Pathway:WP382
d915af39-8747-53d8-bc74-539cb183a60f,Matrix Metalloproteinases WP129,Matrix Metalloproteinases,WP129,https://www.wikipathways.org/index.php/Pathway:WP129
d44b975e-af2c-5faf-a586-e596566ece28,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,mBDNF and proBDNF regulation of GABA neurotransmission,WP4829,https://www.wikipathways.org/index.php/Pathway:WP4829
51df5283-2a7a-53bd-926b-597458561d08,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms,WP4534,https://www.wikipathways.org/index.php/Pathway:WP4534
3ad0038c-cf98-5a18-9de3-b9ad1cb60bfc,MECP2 and Associated Rett Syndrome WP3584,MECP2 and Associated Rett Syndrome,WP3584,https://www.wikipathways.org/index.php/Pathway:WP3584
0c92691c-8250-537d-8935-d6c1a114c761,MED and Pseudoachondroplasia genes WP4789,MED and Pseudoachondroplasia genes,WP4789,https://www.wikipathways.org/index.php/Pathway:WP4789
49507fed-cbca-5591-9e97-56d2ca701e96,Melanoma WP4685,Melanoma,WP4685,https://www.wikipathways.org/index.php/Pathway:WP4685
74c9ef99-ea84-5c18-8799-8f3c9adf05ef,Melatonin metabolism and effects WP3298,Melatonin metabolism and effects,WP3298,https://www.wikipathways.org/index.php/Pathway:WP3298
fbf79e1a-9105-5406-8ff4-9532e98db311,Mesodermal commitment pathway WP2857,Mesodermal commitment pathway,WP2857,https://www.wikipathways.org/index.php/Pathway:WP2857
1048bce3-1606-5b7e-a43d-a1dba294b093,MET in type 1 papillary renal cell carcinoma WP4205,MET in type 1 papillary renal cell carcinoma,WP4205,https://www.wikipathways.org/index.php/Pathway:WP4205
b4e1aa30-4830-502b-a84b-1cf19fa07581,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","Metabolic pathway of LDL, HDL and TG, including diseases",WP4522,https://www.wikipathways.org/index.php/Pathway:WP4522
590a1d07-85dd-50c2-b9ea-225d4ec31eab,Metabolic reprogramming in colon cancer WP4290,Metabolic reprogramming in colon cancer,WP4290,https://www.wikipathways.org/index.php/Pathway:WP4290
6222881f-8ced-5514-bba7-1f6673a59afb,Metabolism of alpha-linolenic acid WP4586,Metabolism of alpha-linolenic acid,WP4586,https://www.wikipathways.org/index.php/Pathway:WP4586
278c6ac6-784e-5ff3-aa1c-604f5c704939,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,Metabolism of Spingolipids in ER and Golgi apparatus,WP4142,https://www.wikipathways.org/index.php/Pathway:WP4142
b7ab9b7e-3599-5b6a-8f14-2817f5207004,Metapathway biotransformation Phase I and II WP702,Metapathway biotransformation Phase I and II,WP702,https://www.wikipathways.org/index.php/Pathway:WP702
4879a34f-2259-5119-bf67-190aced20de0,Metastatic brain tumor WP2249,Metastatic brain tumor,WP2249,https://www.wikipathways.org/index.php/Pathway:WP2249
b74baa35-fd01-5f68-8c0a-cdd116bb1f5d,Methionine De Novo and Salvage Pathway WP3580,Methionine De Novo and Salvage Pathway,WP3580,https://www.wikipathways.org/index.php/Pathway:WP3580
281f9b00-1411-569b-8ef4-a0f137e34dbb,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,Methionine metabolism leading to sulfur amino acids and related disorders,WP4292,https://www.wikipathways.org/index.php/Pathway:WP4292
eef35285-59b1-5df5-98d3-1bc6ede36703,Methylation Pathways WP704,Methylation Pathways,WP704,https://www.wikipathways.org/index.php/Pathway:WP704
c67c479a-219a-5b0e-b988-c06d0a0219ac,Mevalonate arm of cholesterol biosynthesis pathway WP4190,Mevalonate arm of cholesterol biosynthesis pathway,WP4190,https://www.wikipathways.org/index.php/Pathway:WP4190
a8371d41-f652-5e4d-baac-70355b7c24a5,Mevalonate pathway WP3963,Mevalonate pathway,WP3963,https://www.wikipathways.org/index.php/Pathway:WP3963
dfcdf192-a746-5fa3-ba6b-f1d263943d53,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,WP4560,https://www.wikipathways.org/index.php/Pathway:WP4560
48e74108-f34d-598f-9445-80106fab6c4a,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,MFAP5-mediated ovarian cancer cell motility and invasiveness,WP3301,https://www.wikipathways.org/index.php/Pathway:WP3301
d72e3737-a3a6-514a-9d73-828301c25d57,Microglia Pathogen Phagocytosis Pathway WP3937,Microglia Pathogen Phagocytosis Pathway,WP3937,https://www.wikipathways.org/index.php/Pathway:WP3937
2adb2800-b225-5b0d-8b38-a1a7d0167a67,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma,WP3593,https://www.wikipathways.org/index.php/Pathway:WP3593
f05100ea-7e7c-5135-8ed9-a029004ee3ca,MicroRNAs in cardiomyocyte hypertrophy WP1544,MicroRNAs in cardiomyocyte hypertrophy,WP1544,https://www.wikipathways.org/index.php/Pathway:WP1544
9d0c0a61-f21b-55a1-8891-ebeeb93e6869,mir-124 predicted interactions with cell cycle and differentiation  WP3595,mir-124 predicted interactions with cell cycle and differentiation ,WP3595,https://www.wikipathways.org/index.php/Pathway:WP3595
1e852826-10cf-5c1d-a9fb-37438e663702,miR-509-3p alteration of YAP1/ECM axis WP3967,miR-509-3p alteration of YAP1/ECM axis,WP3967,https://www.wikipathways.org/index.php/Pathway:WP3967
a8238471-6998-547c-ac9b-4b8351122945,miR-517 relationship with ARCN1 and USP1 WP3596,miR-517 relationship with ARCN1 and USP1,WP3596,https://www.wikipathways.org/index.php/Pathway:WP3596
6dc0c51e-6e97-54ea-9d12-668216d2a67b,miRNA Biogenesis WP2338,miRNA Biogenesis,WP2338,https://www.wikipathways.org/index.php/Pathway:WP2338
decf7c49-df61-5a24-aec8-201d5c4fa482,miRNA regulation of DNA damage response WP1530,miRNA regulation of DNA damage response,WP1530,https://www.wikipathways.org/index.php/Pathway:WP1530
38e0d03e-a4e2-5a10-9a54-fda618d8a278,miRNA regulation of p53 pathway in prostate cancer WP3982,miRNA regulation of p53 pathway in prostate cancer,WP3982,https://www.wikipathways.org/index.php/Pathway:WP3982
de01d758-0db1-5bd5-ab5f-21da8ac4c125,miRNA regulation of prostate cancer signaling pathways WP3981,miRNA regulation of prostate cancer signaling pathways,WP3981,https://www.wikipathways.org/index.php/Pathway:WP3981
ca42dd82-a75d-500e-b1cd-5dd107659a76,miRNA targets in ECM and membrane receptors WP2911,miRNA targets in ECM and membrane receptors,WP2911,https://www.wikipathways.org/index.php/Pathway:WP2911
cc5e8149-e07d-5453-a29c-5f1b939ce4bd,miRNAs involved in DNA damage response WP1545,miRNAs involved in DNA damage response,WP1545,https://www.wikipathways.org/index.php/Pathway:WP1545
1b4df0d4-0d6d-5fd2-9305-d3b97041b069,miRNAs involvement in the immune response in sepsis WP4329,miRNAs involvement in the immune response in sepsis,WP4329,https://www.wikipathways.org/index.php/Pathway:WP4329
f27ab95b-d020-55aa-9671-fb93f370da33,Mitochondrial CII Assembly WP4920,Mitochondrial CII Assembly,WP4920,https://www.wikipathways.org/index.php/Pathway:WP4920
c6d9d9fd-e8f3-5202-81a4-888693d73039,Mitochondrial CIV Assembly WP4922,Mitochondrial CIV Assembly,WP4922,https://www.wikipathways.org/index.php/Pathway:WP4922
ee51a3e9-c642-524e-8175-107237cb4ad7,Mitochondrial complex I assembly model OXPHOS system WP4324,Mitochondrial complex I assembly model OXPHOS system,WP4324,https://www.wikipathways.org/index.php/Pathway:WP4324
c0ce4448-4e19-5333-b649-2ba886825123,Mitochondrial complex III assembly WP4921,Mitochondrial complex III assembly,WP4921,https://www.wikipathways.org/index.php/Pathway:WP4921
688c9550-f5ca-5dfe-9b42-f288e6772b7b,Mitochondrial fatty acid synthesis pathway WP4317,Mitochondrial fatty acid synthesis pathway,WP4317,https://www.wikipathways.org/index.php/Pathway:WP4317
e5c3ac88-5007-5b22-80a5-df1975ff15be,Mitochondrial Gene Expression WP391,Mitochondrial Gene Expression,WP391,https://www.wikipathways.org/index.php/Pathway:WP391
5dbfbd7e-48a2-518f-9edd-c402d94bb086,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,Mitochondrial LC-Fatty Acid Beta-Oxidation,WP368,https://www.wikipathways.org/index.php/Pathway:WP368
cdba7013-1c38-5d28-b465-76670ebd4d7b,Modulators of TCR signaling and T cell activation WP5072,Modulators of TCR signaling and T cell activation,WP5072,https://www.wikipathways.org/index.php/Pathway:WP5072
9cfcc1e1-f912-52e5-8cac-3676e5cfcf19,Molybdenum cofactor (Moco) biosynthesis WP4507,Molybdenum cofactor (Moco) biosynthesis,WP4507,https://www.wikipathways.org/index.php/Pathway:WP4507
da5c5a1e-e443-5703-a3ec-ce4d3fee321c,Monoamine GPCRs WP58,Monoamine GPCRs,WP58,https://www.wikipathways.org/index.php/Pathway:WP58
dde86001-9188-53e4-b6ea-2e543c2b4ce1,Monoamine Transport WP727,Monoamine Transport,WP727,https://www.wikipathways.org/index.php/Pathway:WP727
7a08ae27-db65-5371-9444-90104d953094,mRNA Processing WP411,mRNA Processing,WP411,https://www.wikipathways.org/index.php/Pathway:WP411
92503886-13c9-594c-b15c-6a3c45a1a751,MTHFR deficiency WP4288,MTHFR deficiency,WP4288,https://www.wikipathways.org/index.php/Pathway:WP4288
300851fd-5e68-58ed-82f6-66e32cda8290,Myometrial relaxation and contraction pathways WP289,Myometrial relaxation and contraction pathways,WP289,https://www.wikipathways.org/index.php/Pathway:WP289
e31df075-b2f6-5304-95d0-711f58d5e2a7,NAD Biosynthesis II (from tryptophan) WP2485,NAD Biosynthesis II (from tryptophan),WP2485,https://www.wikipathways.org/index.php/Pathway:WP2485
e646af1a-c4a0-548e-9802-b614860fe0d4,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence,WP5046,https://www.wikipathways.org/index.php/Pathway:WP5046
e0140da8-e2f6-5f77-b6e4-85b908d0ef85,"NAD metabolism, sirtuins and aging WP3630","NAD metabolism, sirtuins and aging",WP3630,https://www.wikipathways.org/index.php/Pathway:WP3630
17112644-8522-501d-8cf3-c6d9106d93ac,NAD+ biosynthetic pathways WP3645,NAD+ biosynthetic pathways,WP3645,https://www.wikipathways.org/index.php/Pathway:WP3645
f04833e7-90ce-5063-805f-c2809a7e2485,NAD+ metabolism WP3644,NAD+ metabolism,WP3644,https://www.wikipathways.org/index.php/Pathway:WP3644
c540e77a-1ad9-5651-8384-6e5539c2ac04,Nanomaterial induced apoptosis WP2507,Nanomaterial induced apoptosis,WP2507,https://www.wikipathways.org/index.php/Pathway:WP2507
ad108fe2-eaae-588b-84ea-fe18347c9f5d,Nanomaterial-induced inflammasome activation WP3890,Nanomaterial-induced inflammasome activation,WP3890,https://www.wikipathways.org/index.php/Pathway:WP3890
1ea30a5f-299f-5659-8752-11c44db29666,Nanoparticle triggered autophagic cell death WP2509,Nanoparticle triggered autophagic cell death,WP2509,https://www.wikipathways.org/index.php/Pathway:WP2509
dfb30e48-c79e-53c5-81d5-5566c12e10c6,Nanoparticle triggered regulated necrosis WP2513,Nanoparticle triggered regulated necrosis,WP2513,https://www.wikipathways.org/index.php/Pathway:WP2513
6c306932-8c39-54c5-bdec-07eb8887ac42,Nanoparticle-mediated activation of receptor signaling WP2643,Nanoparticle-mediated activation of receptor signaling,WP2643,https://www.wikipathways.org/index.php/Pathway:WP2643
7f385aad-8770-52a3-adf0-4d8e933731b8,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,WP4337,https://www.wikipathways.org/index.php/Pathway:WP4337
bfe11c31-6527-5418-95e1-332412e6ca49,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,WP4336,https://www.wikipathways.org/index.php/Pathway:WP4336
9cbddf5e-e553-548b-b0ea-22dba3cef6db,Neovascularisation processes WP4331,Neovascularisation processes,WP4331,https://www.wikipathways.org/index.php/Pathway:WP4331
bdf361d6-88c1-58a7-b849-f1f7dd813ea3,Nephrogenesis WP5052,Nephrogenesis,WP5052,https://www.wikipathways.org/index.php/Pathway:WP5052
f9646e2c-dc64-521d-88b0-366db24a1e82,Nephrotic syndrome WP4758,Nephrotic syndrome,WP4758,https://www.wikipathways.org/index.php/Pathway:WP4758
3af37f7b-2b0b-5b31-bed0-1ff82ba2554c,Netrin-UNC5B signaling pathway WP4747,Netrin-UNC5B signaling pathway,WP4747,https://www.wikipathways.org/index.php/Pathway:WP4747
e491ca3b-08f6-5326-bc8f-0fc29144db92,Neural Crest Cell Migration during Development WP4564,Neural Crest Cell Migration during Development,WP4564,https://www.wikipathways.org/index.php/Pathway:WP4564
9269509e-e6da-50c9-82b3-e888ad150749,Neural Crest Cell Migration in Cancer WP4565,Neural Crest Cell Migration in Cancer,WP4565,https://www.wikipathways.org/index.php/Pathway:WP4565
c8320892-7985-5205-bcf7-b6039e5a091e,Neural Crest Differentiation WP2064,Neural Crest Differentiation,WP2064,https://www.wikipathways.org/index.php/Pathway:WP2064
c888f651-edfe-5782-b65f-a1d8c7e18d62,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,WP4577,https://www.wikipathways.org/index.php/Pathway:WP4577
bf37a2fc-f521-5799-b562-3c15263aa8a0,Neuroinflammation WP4919,Neuroinflammation,WP4919,https://www.wikipathways.org/index.php/Pathway:WP4919
6f9d768e-79d0-5304-8058-92250c02940b,Nicotine Activity on Dopaminergic Neurons WP1602,Nicotine Activity on Dopaminergic Neurons,WP1602,https://www.wikipathways.org/index.php/Pathway:WP1602
ed7577fa-174c-5ff1-a11f-0ba13e3bf817,Nicotine Metabolism WP1600,Nicotine Metabolism,WP1600,https://www.wikipathways.org/index.php/Pathway:WP1600
867a7d47-fc11-5c6c-8d94-265fba13a861,NLR Proteins WP288,NLR Proteins,WP288,https://www.wikipathways.org/index.php/Pathway:WP288
a8565451-41ab-5feb-b08e-2384fef98c99,NO metabolism in cystic fibrosis WP4947,NO metabolism in cystic fibrosis,WP4947,https://www.wikipathways.org/index.php/Pathway:WP4947
14a33585-1aaf-5279-9652-1c2b41e74de2,NO/cGMP/PKG mediated Neuroprotection WP4008,NO/cGMP/PKG mediated Neuroprotection,WP4008,https://www.wikipathways.org/index.php/Pathway:WP4008
47b9b57e-b7f4-5830-abf2-af9c205dbb71,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341","Non-genomic actions of 1,25 dihydroxyvitamin D3",WP4341,https://www.wikipathways.org/index.php/Pathway:WP4341
1bd5d66d-1f5a-5b60-bc25-aa8ee55790b1,Non-homologous end joining WP438,Non-homologous end joining,WP438,https://www.wikipathways.org/index.php/Pathway:WP438
b02eb843-694c-5d98-8275-afbc1b403fce,Non-small cell lung cancer WP4255,Non-small cell lung cancer,WP4255,https://www.wikipathways.org/index.php/Pathway:WP4255
c0a65174-446f-5e9a-9944-9680ad5de270,Nonalcoholic fatty liver disease WP4396,Nonalcoholic fatty liver disease,WP4396,https://www.wikipathways.org/index.php/Pathway:WP4396
53db87b7-4b41-593f-a3b1-a9b7b9ce18da,Notch Signaling Pathway Netpath WP61,Notch Signaling Pathway Netpath,WP61,https://www.wikipathways.org/index.php/Pathway:WP61
91a2bda9-91ba-5aaa-91f9-ec5037911a99,Notch Signaling WP268,Notch Signaling,WP268,https://www.wikipathways.org/index.php/Pathway:WP268
38aca381-6999-55a0-8f25-a628e3b50f46,NOTCH1 regulation of endothelial cell calcification WP3413,NOTCH1 regulation of endothelial cell calcification,WP3413,https://www.wikipathways.org/index.php/Pathway:WP3413
b198929e-7f54-5234-bf77-2a10e005f701,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,Novel intracellular components of RIG-I-like receptor (RLR) pathway,WP3865,https://www.wikipathways.org/index.php/Pathway:WP3865
02692578-d705-5a2c-9c2b-df374aff5e03,NRF2 pathway WP2884,NRF2 pathway,WP2884,https://www.wikipathways.org/index.php/Pathway:WP2884
a53f2c76-298b-59a4-adb5-9bfc16902451,NRF2-ARE regulation WP4357,NRF2-ARE regulation,WP4357,https://www.wikipathways.org/index.php/Pathway:WP4357
8591d933-f57b-53fa-a1eb-e1736461eea3,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,WP5027,https://www.wikipathways.org/index.php/Pathway:WP5027
ae737298-5514-5365-885e-f23ee157ab2f,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,Nuclear Receptors in Lipid Metabolism and Toxicity,WP299,https://www.wikipathways.org/index.php/Pathway:WP299
0ada7524-489b-55f7-ac54-02eb9e500b53,Nuclear Receptors Meta-Pathway WP2882,Nuclear Receptors Meta-Pathway,WP2882,https://www.wikipathways.org/index.php/Pathway:WP2882
67a8cc1e-ecda-56b3-9311-56d4375c3212,Nuclear receptors WP170,Nuclear receptors,WP170,https://www.wikipathways.org/index.php/Pathway:WP170
046705be-9f1b-5d70-9fa8-4f158015dd6f,Nucleotide Excision Repair WP4753,Nucleotide Excision Repair,WP4753,https://www.wikipathways.org/index.php/Pathway:WP4753
3d8905fb-bb34-540c-a46d-fca5f606aec0,Nucleotide GPCRs WP80,Nucleotide GPCRs,WP80,https://www.wikipathways.org/index.php/Pathway:WP80
a1339da8-09f0-5fcc-9017-7a83b68dab1e,Nucleotide metabolism WP404,Nucleotide metabolism,WP404,https://www.wikipathways.org/index.php/Pathway:WP404
e158059a-a383-5fac-b129-cbd177c59b6b,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,Nucleotide-binding Oligomerization Domain (NOD) pathway,WP1433,https://www.wikipathways.org/index.php/Pathway:WP1433
289932be-c3f0-5174-9f28-f2a4c21b208e,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304","Oligodendrocyte specification and differentiation, leading to myelin components for CNS",WP4304,https://www.wikipathways.org/index.php/Pathway:WP4304
b205ed77-bd8c-5270-a377-5677eb1722bc,Omega-3/Omega-6 FA synthesis WP4723,Omega-3/Omega-6 FA synthesis,WP4723,https://www.wikipathways.org/index.php/Pathway:WP4723
3a478ffc-b833-5db7-bb88-415c88fad3ea,Omega-9 FA synthesis WP4724,Omega-9 FA synthesis,WP4724,https://www.wikipathways.org/index.php/Pathway:WP4724
ad5411e6-d819-5018-8821-50e40d2c3576,Oncostatin M Signaling Pathway WP2374,Oncostatin M Signaling Pathway,WP2374,https://www.wikipathways.org/index.php/Pathway:WP2374
a60d98aa-3cd2-59e1-9c86-9369a055b6e5,One-carbon metabolism and related pathways WP3940,One-carbon metabolism and related pathways,WP3940,https://www.wikipathways.org/index.php/Pathway:WP3940
9195177e-14e7-5c6d-9c68-f61b7055baed,One-carbon metabolism WP241,One-carbon metabolism,WP241,https://www.wikipathways.org/index.php/Pathway:WP241
a4c45492-6040-5d07-9e06-51adfee1136b,Osteoblast differentiation WP4787,Osteoblast differentiation,WP4787,https://www.wikipathways.org/index.php/Pathway:WP4787
de5380ea-493a-5316-9d6f-98bb5a24ad73,Osteoblast Signaling WP322,Osteoblast Signaling,WP322,https://www.wikipathways.org/index.php/Pathway:WP322
a8bd40d2-ab27-5763-9dda-7aa13ef52963,Osteoclast Signaling WP12,Osteoclast Signaling,WP12,https://www.wikipathways.org/index.php/Pathway:WP12
c0fed6d8-d42f-5b23-8c8d-5d797ab0657b,Osteopontin Signaling WP1434,Osteopontin Signaling,WP1434,https://www.wikipathways.org/index.php/Pathway:WP1434
46a2ebb7-631b-5b77-9695-697d0b0ceeab,Ovarian infertility WP34,Ovarian infertility,WP34,https://www.wikipathways.org/index.php/Pathway:WP34
830fdcf8-c156-5d27-b01b-f2097cc4b445,Overview of interferons-mediated signaling pathway WP4558,Overview of interferons-mediated signaling pathway,WP4558,https://www.wikipathways.org/index.php/Pathway:WP4558
ac5a1d08-fda7-5615-b7b3-eaf9ba09c031,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,Overview of leukocyte-intrinsic Hippo pathway functions,WP4542,https://www.wikipathways.org/index.php/Pathway:WP4542
44fe7bda-068a-527c-861a-44e8d6d5dfd0,Overview of nanoparticle effects WP3287,Overview of nanoparticle effects,WP3287,https://www.wikipathways.org/index.php/Pathway:WP3287
89458abd-8cab-5398-bb8a-1fe18b9508ed,Oxidation by Cytochrome P450 WP43,Oxidation by Cytochrome P450,WP43,https://www.wikipathways.org/index.php/Pathway:WP43
13a32d81-2b2f-52d6-9ce2-576006f2a2f5,Oxidative Damage WP3941,Oxidative Damage,WP3941,https://www.wikipathways.org/index.php/Pathway:WP3941
029bfe8e-e805-5278-80e4-b235ede869cf,Oxidative phosphorylation WP623,Oxidative phosphorylation,WP623,https://www.wikipathways.org/index.php/Pathway:WP623
f5b0e739-37ec-58db-a7c8-02672e3765e9,Oxidative Stress WP408,Oxidative Stress,WP408,https://www.wikipathways.org/index.php/Pathway:WP408
b406d875-d95b-5e88-9570-51ebf537fe69,Oxysterols derived from cholesterol WP4545,Oxysterols derived from cholesterol,WP4545,https://www.wikipathways.org/index.php/Pathway:WP4545
412c0b9a-5b75-5917-a699-d6ec7b902929,p38 MAPK Signaling Pathway WP400,p38 MAPK Signaling Pathway,WP400,https://www.wikipathways.org/index.php/Pathway:WP400
a4cd3d3b-cc5c-56aa-9e94-0e3cf8a97cd1,p53 transcriptional gene network WP4963,p53 transcriptional gene network,WP4963,https://www.wikipathways.org/index.php/Pathway:WP4963
01ff76f2-7b77-570a-9611-0d005e693df6,Pancreatic adenocarcinoma pathway WP4263,Pancreatic adenocarcinoma pathway,WP4263,https://www.wikipathways.org/index.php/Pathway:WP4263
e27df309-b075-52c2-8f65-c20daef7018b,Parkin-Ubiquitin Proteasomal System pathway WP2359,Parkin-Ubiquitin Proteasomal System pathway,WP2359,https://www.wikipathways.org/index.php/Pathway:WP2359
ab764538-1137-5054-bb62-4acc4e1baef8,Parkinson's disease pathway WP2371,Parkinson's disease pathway,WP2371,https://www.wikipathways.org/index.php/Pathway:WP2371
f3b6b14b-7ec0-57f6-a7d0-5ff40af17a65,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex,WP4884,https://www.wikipathways.org/index.php/Pathway:WP4884
874b687c-f9fb-55c1-a2db-c9c211ceaf2f,Pathogenic Escherichia coli infection WP2272,Pathogenic Escherichia coli infection,WP2272,https://www.wikipathways.org/index.php/Pathway:WP2272
4655af17-1171-521f-919e-bd5a3dd4c734,Pathways affected in adenoid cystic carcinoma WP3651,Pathways affected in adenoid cystic carcinoma,WP3651,https://www.wikipathways.org/index.php/Pathway:WP3651
a3e2a9d7-f4c5-5175-b4e4-7c0460267cc5,Pathways in clear cell renal cell carcinoma WP4018,Pathways in clear cell renal cell carcinoma,WP4018,https://www.wikipathways.org/index.php/Pathway:WP4018
6660fb65-f811-546b-ac11-1333989a9e6e,Pathways of nucleic acid metabolism and innate immune sensing WP4705,Pathways of nucleic acid metabolism and innate immune sensing,WP4705,https://www.wikipathways.org/index.php/Pathway:WP4705
cd703b8f-f893-5897-8d2a-95b52ae235dd,Pathways Regulating Hippo Signaling WP4540,Pathways Regulating Hippo Signaling,WP4540,https://www.wikipathways.org/index.php/Pathway:WP4540
55a6515f-7b87-5e7f-853e-9f803c864bc6,PDGF Pathway WP2526,PDGF Pathway,WP2526,https://www.wikipathways.org/index.php/Pathway:WP2526
fd06c643-d76e-594f-bda1-21f3d71b86d4,PDGFR-beta pathway WP3972,PDGFR-beta pathway,WP3972,https://www.wikipathways.org/index.php/Pathway:WP3972
625c4626-fa2e-5e35-a0e1-870920ad7de2,Pentose Phosphate Metabolism WP134,Pentose Phosphate Metabolism,WP134,https://www.wikipathways.org/index.php/Pathway:WP134
d61543e1-aa10-5858-9f3a-7deed89344d1,Peptide GPCRs WP24,Peptide GPCRs,WP24,https://www.wikipathways.org/index.php/Pathway:WP24
5a2c83d1-95f4-555e-b2bb-3876fa9f70cb,Peroxiredoxin 2 induced ovarian failure WP4873,Peroxiredoxin 2 induced ovarian failure,WP4873,https://www.wikipathways.org/index.php/Pathway:WP4873
52d46a63-4422-599f-ba38-993cafc4e7b5,"Phase I biotransformations, non P450 WP136","Phase I biotransformations, non P450",WP136,https://www.wikipathways.org/index.php/Pathway:WP136
852e6461-b7fd-575f-94ce-51a800dddf90,Phosphodiesterases in neuronal function WP4222,Phosphodiesterases in neuronal function,WP4222,https://www.wikipathways.org/index.php/Pathway:WP4222
82798966-d3f0-5ef8-a44a-95c87d82c375,Phosphoinositides metabolism WP4971,Phosphoinositides metabolism,WP4971,https://www.wikipathways.org/index.php/Pathway:WP4971
acbb2066-4069-5653-b383-7c90a5efbefe,Photodynamic therapy-induced AP-1 survival signaling. WP3611,Photodynamic therapy-induced AP-1 survival signaling.,WP3611,https://www.wikipathways.org/index.php/Pathway:WP3611
ee0a6997-5387-5ce0-92f2-c2ed5d19d897,Photodynamic therapy-induced HIF-1 survival signaling WP3614,Photodynamic therapy-induced HIF-1 survival signaling,WP3614,https://www.wikipathways.org/index.php/Pathway:WP3614
a6b10b5b-c34d-5138-9a01-e90a4c083cdf,Photodynamic therapy-induced NF-kB survival signaling WP3617,Photodynamic therapy-induced NF-kB survival signaling,WP3617,https://www.wikipathways.org/index.php/Pathway:WP3617
57a63524-6745-5406-b158-cd88bebff186,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,WP3612,https://www.wikipathways.org/index.php/Pathway:WP3612
5dee5cd4-ac12-5d56-b429-efdbdd539327,Photodynamic therapy-induced unfolded protein response WP3613,Photodynamic therapy-induced unfolded protein response,WP3613,https://www.wikipathways.org/index.php/Pathway:WP3613
6fcbf94b-0f50-532a-9f41-ecd20bd85d24,Physiological and pathological hypertrophy of the heart WP1528,Physiological and pathological hypertrophy of the heart,WP1528,https://www.wikipathways.org/index.php/Pathway:WP1528
02165ab1-6281-5783-abc9-9a39b02cf486,Phytochemical activity on NRF2 transcriptional activation WP3,Phytochemical activity on NRF2 transcriptional activation,WP3,https://www.wikipathways.org/index.php/Pathway:WP3
91eca660-7f86-582d-959d-e60ba5073a40,PI3K-Akt signaling pathway WP4172,PI3K-Akt signaling pathway,WP4172,https://www.wikipathways.org/index.php/Pathway:WP4172
f80e3e2b-da95-55b6-8af8-e49314b27ae2,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities,WP3844,https://www.wikipathways.org/index.php/Pathway:WP3844
d5534882-4006-5aa9-934f-cfa260167409,PI3K/AKT/mTOR - VitD3 signaling WP4141,PI3K/AKT/mTOR - VitD3 signaling,WP4141,https://www.wikipathways.org/index.php/Pathway:WP4141
7e720194-937f-5796-83a8-f0d6cde4b0cd,Pilocytic astrocytoma WP2253,Pilocytic astrocytoma,WP2253,https://www.wikipathways.org/index.php/Pathway:WP2253
a0fd9691-e19d-5d49-af90-b8a1d438fa53,PKC-gamma calcium signaling pathway in ataxia WP4760,PKC-gamma calcium signaling pathway in ataxia,WP4760,https://www.wikipathways.org/index.php/Pathway:WP4760
84fe642d-a79c-57b4-8e51-00603dd23f54,Platelet-mediated interactions with vascular and circulating cells WP4462,Platelet-mediated interactions with vascular and circulating cells,WP4462,https://www.wikipathways.org/index.php/Pathway:WP4462
29e22385-a238-5ed1-8f4d-97d9c4d05248,PPAR signaling pathway WP3942,PPAR signaling pathway,WP3942,https://www.wikipathways.org/index.php/Pathway:WP3942
d2b17cd5-785a-522f-9cc8-fed0f128977d,PPAR-alpha pathway WP2878,PPAR-alpha pathway,WP2878,https://www.wikipathways.org/index.php/Pathway:WP2878
04a12891-a6c6-501c-a699-0f45fa937ea4,Prader-Willi and Angelman Syndrome WP3998,Prader-Willi and Angelman Syndrome,WP3998,https://www.wikipathways.org/index.php/Pathway:WP3998
e331179d-59f6-5b0f-b96f-3ff413dcdcef,Pre-implantation embryo WP3527,Pre-implantation embryo,WP3527,https://www.wikipathways.org/index.php/Pathway:WP3527
87609717-a346-5714-9ba0-8f5dfd47ae9c,Pregnane X receptor pathway WP2876,Pregnane X receptor pathway,WP2876,https://www.wikipathways.org/index.php/Pathway:WP2876
f27a6f0d-5ee7-5db8-9e0d-b931b546c7a0,Primary focal segmental glomerulosclerosis (FSGS) WP2572,Primary focal segmental glomerulosclerosis (FSGS),WP2572,https://www.wikipathways.org/index.php/Pathway:WP2572
2ec9b7be-475d-56e4-96ec-fa34b2d7881f,Prion disease pathway WP3995,Prion disease pathway,WP3995,https://www.wikipathways.org/index.php/Pathway:WP3995
e2865b75-517b-5741-9699-855032bfbd2e,Prolactin Signaling Pathway WP2037,Prolactin Signaling Pathway,WP2037,https://www.wikipathways.org/index.php/Pathway:WP2037
b659503d-b688-5990-a59c-a5065cd5893b,Prostaglandin Synthesis and Regulation WP98,Prostaglandin Synthesis and Regulation,WP98,https://www.wikipathways.org/index.php/Pathway:WP98
1fb489b0-0411-5d55-8ca8-4e2cd4483d1a,Proteasome Degradation WP183,Proteasome Degradation,WP183,https://www.wikipathways.org/index.php/Pathway:WP183
ed02b565-fe48-55ea-9e26-1f07b2d94ce4,Proteoglycan biosynthesis WP4784,Proteoglycan biosynthesis,WP4784,https://www.wikipathways.org/index.php/Pathway:WP4784
ab5aa183-fe9a-5e3e-9b0f-0b8f17a6ae3c,Proximal tubule transport WP4917,Proximal tubule transport,WP4917,https://www.wikipathways.org/index.php/Pathway:WP4917
4b78ccf7-63f0-582f-95a9-30ad64b360d5,PTF1A related regulatory pathway WP4147,PTF1A related regulatory pathway,WP4147,https://www.wikipathways.org/index.php/Pathway:WP4147
3b63a301-2c8f-59cf-a769-5d6a3af1bea8,Purine metabolism and related disorders WP4224,Purine metabolism and related disorders,WP4224,https://www.wikipathways.org/index.php/Pathway:WP4224
35e27982-832a-597f-b0a2-cb667bc40375,Purine metabolism WP4792,Purine metabolism,WP4792,https://www.wikipathways.org/index.php/Pathway:WP4792
9f82eb58-3876-5921-8431-e30e283cf200,Purinergic signaling WP4900,Purinergic signaling,WP4900,https://www.wikipathways.org/index.php/Pathway:WP4900
376ea9d2-ab54-5738-8e73-09691e5eacaa,Pyrimidine metabolism and related diseases WP4225,Pyrimidine metabolism and related diseases,WP4225,https://www.wikipathways.org/index.php/Pathway:WP4225
c786229f-57a1-5860-adae-9c121f98ae3f,Pyrimidine metabolism WP4022,Pyrimidine metabolism,WP4022,https://www.wikipathways.org/index.php/Pathway:WP4022
835d9740-715c-5993-9c92-cba992378369,RAC1/PAK1/p38/MMP2 Pathway WP3303,RAC1/PAK1/p38/MMP2 Pathway,WP3303,https://www.wikipathways.org/index.php/Pathway:WP3303
88fc0567-3d02-5799-9c02-3cb36f116038,RalA downstream regulated genes WP2290,RalA downstream regulated genes,WP2290,https://www.wikipathways.org/index.php/Pathway:WP2290
e84e0037-5946-566e-bc3a-caa0589d0ed5,RANKL/RANK signaling pathway WP2018,RANKL/RANK signaling pathway,WP2018,https://www.wikipathways.org/index.php/Pathway:WP2018
3168200c-cee2-5e37-bf37-e99bacf6d2e4,RAS and bradykinin pathways in COVID-19 WP4969,RAS and bradykinin pathways in COVID-19,WP4969,https://www.wikipathways.org/index.php/Pathway:WP4969
37b6e276-d665-53e0-aa89-f71fa5e3a320,Ras signaling WP4223,Ras signaling,WP4223,https://www.wikipathways.org/index.php/Pathway:WP4223
e0e9e87a-497d-5ad8-aba6-96884d7706d9,Regucalcin in proximal tubule epithelial kidney cells WP4838,Regucalcin in proximal tubule epithelial kidney cells,WP4838,https://www.wikipathways.org/index.php/Pathway:WP4838
151c1aad-4778-57e2-9f2d-e40306b53882,Regulation of Actin Cytoskeleton WP51,Regulation of Actin Cytoskeleton,WP51,https://www.wikipathways.org/index.php/Pathway:WP51
15eff278-918c-51a6-95d4-96812e30b206,Regulation of apoptosis by parathyroid hormone-related protein WP3872,Regulation of apoptosis by parathyroid hormone-related protein,WP3872,https://www.wikipathways.org/index.php/Pathway:WP3872
73a7c6bd-00b1-5252-b6b4-e4382d7e9ec1,Regulation of Microtubule Cytoskeleton WP2038,Regulation of Microtubule Cytoskeleton,WP2038,https://www.wikipathways.org/index.php/Pathway:WP2038
a6f7c470-b706-5891-af0f-f281ac301d7f,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,Regulation of sister chromatid separation at the metaphase-anaphase transition,WP4240,https://www.wikipathways.org/index.php/Pathway:WP4240
e449dcb2-bfa6-5f99-ab54-216807ed9ebf,Regulation of toll-like receptor signaling pathway WP1449,Regulation of toll-like receptor signaling pathway,WP1449,https://www.wikipathways.org/index.php/Pathway:WP1449
f1a97c80-07ac-5c7c-ba5a-adf9dd43a38a,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds,WP3664,https://www.wikipathways.org/index.php/Pathway:WP3664
b9b9bb77-21b6-5108-bae0-9a82744ee573,Regulatory circuits of the STAT3 signaling pathway WP4538,Regulatory circuits of the STAT3 signaling pathway,WP4538,https://www.wikipathways.org/index.php/Pathway:WP4538
626a6a4e-c68a-51a1-bf23-fb6302585fd9,"Relationship between inflammation, COX-2 and EGFR WP4483","Relationship between inflammation, COX-2 and EGFR",WP4483,https://www.wikipathways.org/index.php/Pathway:WP4483
a7d905e2-016f-5a1f-a3ec-bd2518870e5a,Renin-angiotensin-aldosterone system (RAAS) WP4756,Renin-angiotensin-aldosterone system (RAAS),WP4756,https://www.wikipathways.org/index.php/Pathway:WP4756
6f924b57-baeb-5826-b3ca-f5b8c21de878,Resistin as a regulator of inflammation WP4481,Resistin as a regulator of inflammation,WP4481,https://www.wikipathways.org/index.php/Pathway:WP4481
d281cfd8-e05d-56f7-9700-a190db51b7fe,Retinoblastoma gene in cancer WP2446,Retinoblastoma gene in cancer,WP2446,https://www.wikipathways.org/index.php/Pathway:WP2446
c74c05c0-354d-5d5d-a07d-f86136a7c3cb,Rett syndrome causing genes WP4312,Rett syndrome causing genes,WP4312,https://www.wikipathways.org/index.php/Pathway:WP4312
d07b17a0-a089-5e49-ae51-69403c4853cd,Riboflavin and CoQ disorders WP5037,Riboflavin and CoQ disorders,WP5037,https://www.wikipathways.org/index.php/Pathway:WP5037
40029878-c2ae-533b-9817-debdbbb86968,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,Robo4 and VEGF Signaling Pathways Crosstalk,WP3943,https://www.wikipathways.org/index.php/Pathway:WP3943
2d54bd0e-cc0b-5b8a-80ee-d91bbb55fba4,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment,WP4480,https://www.wikipathways.org/index.php/Pathway:WP4480
5aa37260-c543-5dd3-bc4d-b01fceeb13c2,Role of Osx and miRNAs in tooth development WP3971,Role of Osx and miRNAs in tooth development,WP3971,https://www.wikipathways.org/index.php/Pathway:WP3971
8e3af80d-da19-59bc-ae81-e01543cc7342,SARS coronavirus and innate immunity WP4912,SARS coronavirus and innate immunity,WP4912,https://www.wikipathways.org/index.php/Pathway:WP4912
41c01938-7a9e-59fe-9642-6dfb4f4877fa,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,SARS-CoV-2 altering angiogenesis via NRP1,WP5065,https://www.wikipathways.org/index.php/Pathway:WP5065
694e1dfc-b2db-5aa6-8b1e-2f239dce3c22,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms,WP4883,https://www.wikipathways.org/index.php/Pathway:WP4883
c1cf0527-a68e-53f8-9735-4d0c88e5c796,SARS-CoV-2 and COVID-19 Pathway WP4846,SARS-CoV-2 and COVID-19 Pathway,WP4846,https://www.wikipathways.org/index.php/Pathway:WP4846
b167ee9e-639a-525a-b9ab-971dea2b934e,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,SARS-CoV-2 innate immunity evasion and cell-specific immune response,WP5039,https://www.wikipathways.org/index.php/Pathway:WP5039
895befd5-45dd-5af6-8b64-3e593d55fc01,SARS-CoV-2 mitochondrial interactions WP5038,SARS-CoV-2 mitochondrial interactions,WP5038,https://www.wikipathways.org/index.php/Pathway:WP5038
339488b1-f871-53f1-a744-c18c784fade2,SCFA and skeletal muscle substrate metabolism WP4030,SCFA and skeletal muscle substrate metabolism,WP4030,https://www.wikipathways.org/index.php/Pathway:WP4030
07d1a116-ae63-5553-8be7-a649663b6a86,Secretion of Hydrochloric Acid in Parietal Cells WP2597,Secretion of Hydrochloric Acid in Parietal Cells,WP2597,https://www.wikipathways.org/index.php/Pathway:WP2597
d83c3807-3ca6-57a1-94bc-156a3b874e9b,Selective expression of chemokine receptors during T-cell polarization WP4494,Selective expression of chemokine receptors during T-cell polarization,WP4494,https://www.wikipathways.org/index.php/Pathway:WP4494
186b0721-74a9-53e4-8007-30aa455d6a50,Selenium Micronutrient Network WP15,Selenium Micronutrient Network,WP15,https://www.wikipathways.org/index.php/Pathway:WP15
94adb34e-a36b-5cd1-b546-74254cdb5e0b,Senescence and Autophagy in Cancer WP615,Senescence and Autophagy in Cancer,WP615,https://www.wikipathways.org/index.php/Pathway:WP615
d46f4d84-dfd5-5b07-a2bf-25c3f228021c,Serine Metabolism WP4688,Serine Metabolism,WP4688,https://www.wikipathways.org/index.php/Pathway:WP4688
0ed48a3f-85e6-5986-b081-03943867c788,Serotonin and anxiety WP3947,Serotonin and anxiety,WP3947,https://www.wikipathways.org/index.php/Pathway:WP3947
45c05839-5e55-5e3e-8a3c-1bc2ac9b7426,Serotonin and anxiety-related events WP3944,Serotonin and anxiety-related events,WP3944,https://www.wikipathways.org/index.php/Pathway:WP3944
62d62b1f-5b3d-506e-b428-e64c0b07eada,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling,WP732,https://www.wikipathways.org/index.php/Pathway:WP732
b6ad97fd-1f04-5763-b0ea-afcfb7e4611b,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,Serotonin Receptor 4/6/7 and NR3C Signaling,WP734,https://www.wikipathways.org/index.php/Pathway:WP734
259295ed-aa1d-5494-8a22-a30b08036403,Serotonin Transporter Activity WP1455,Serotonin Transporter Activity,WP1455,https://www.wikipathways.org/index.php/Pathway:WP1455
09804d1b-887d-500a-99df-fd263af507a5,Signal Transduction of S1P Receptor WP26,Signal Transduction of S1P Receptor,WP26,https://www.wikipathways.org/index.php/Pathway:WP26
5612a40e-7461-57c6-93ac-8723ab318974,Signal transduction through IL1R WP4496,Signal transduction through IL1R,WP4496,https://www.wikipathways.org/index.php/Pathway:WP4496
dd961bcc-d608-534e-a44d-acaceae33e56,Signaling of Hepatocyte Growth Factor Receptor WP313,Signaling of Hepatocyte Growth Factor Receptor,WP313,https://www.wikipathways.org/index.php/Pathway:WP313
dc134473-ec62-53aa-b9ed-e6e1b9dd41e2,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,Simplified Depiction of MYD88 Distinct Input-Output Pathway,WP3877,https://www.wikipathways.org/index.php/Pathway:WP3877
59dc7311-833c-53f6-8aaa-211966bf2ebd,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway,WP3670,https://www.wikipathways.org/index.php/Pathway:WP3670
ab4dbfd6-9a16-5824-a779-bdaa6e7c7166,Sleep regulation WP3591,Sleep regulation,WP3591,https://www.wikipathways.org/index.php/Pathway:WP3591
e2a3011d-f827-5d07-899e-fcfde77d866e,Small cell lung cancer WP4658,Small cell lung cancer,WP4658,https://www.wikipathways.org/index.php/Pathway:WP4658
1bfd18ae-8d77-50c1-8750-cec4628ab24f,Small Ligand GPCRs WP247,Small Ligand GPCRs,WP247,https://www.wikipathways.org/index.php/Pathway:WP247
21862cb9-dc25-5bb5-90f6-a476d971bbc0,Somatic sex determination WP4814,Somatic sex determination,WP4814,https://www.wikipathways.org/index.php/Pathway:WP4814
965b5a84-3f64-5aa6-af59-1bd2025d08ad,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,Somatroph axis (GH) and its relationship to dietary restriction and aging,WP4186,https://www.wikipathways.org/index.php/Pathway:WP4186
4bfa474c-f089-53cd-886f-29705ce0932a,Somitogenesis in the context of spondylocostal dysostosis WP4785,Somitogenesis in the context of spondylocostal dysostosis,WP4785,https://www.wikipathways.org/index.php/Pathway:WP4785
f8b8c2b8-cc6e-5c15-b4c5-00e1b3da1f2f,Sphingolipid Metabolism (general overview) WP4725,Sphingolipid Metabolism (general overview),WP4725,https://www.wikipathways.org/index.php/Pathway:WP4725
8d210225-e89d-52a7-9504-19b4706ae1e1,Sphingolipid Metabolism (integrated pathway) WP4726,Sphingolipid Metabolism (integrated pathway),WP4726,https://www.wikipathways.org/index.php/Pathway:WP4726
1fe6e47f-90c9-5403-a9bf-223d4301894f,Sphingolipid pathway WP1422,Sphingolipid pathway,WP1422,https://www.wikipathways.org/index.php/Pathway:WP1422
28811a30-1d50-5bf8-a873-17f17a54c092,Spinal Cord Injury WP2431,Spinal Cord Injury,WP2431,https://www.wikipathways.org/index.php/Pathway:WP2431
ab024aa3-19e9-5483-b8b0-cef32f6806f0,Splicing factor NOVA regulated synaptic proteins WP4148,Splicing factor NOVA regulated synaptic proteins,WP4148,https://www.wikipathways.org/index.php/Pathway:WP4148
70a7cfb9-09c2-5fa7-97ea-7f1b06e3ea48,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,SREBF and miR33 in cholesterol and lipid homeostasis,WP2011,https://www.wikipathways.org/index.php/Pathway:WP2011
f8c3696c-12e7-5864-890e-04cd987a93dd,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,SRF and miRs in Smooth Muscle Differentiation and Proliferation,WP1991,https://www.wikipathways.org/index.php/Pathway:WP1991
7b66d352-e156-552d-8354-a5e60299d599,Statin inhibition of cholesterol production WP430,Statin inhibition of cholesterol production,WP430,https://www.wikipathways.org/index.php/Pathway:WP430
7ad3beb6-290b-5cee-afb9-21b227f10031,Steroid Biosynthesis WP496,Steroid Biosynthesis,WP496,https://www.wikipathways.org/index.php/Pathway:WP496
1ecaca0e-b814-5065-9faa-f2d02c5b4cc4,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,Sterol regulatory element-binding proteins (SREBP) signaling,WP1982,https://www.wikipathways.org/index.php/Pathway:WP1982
d6c36da2-ef44-514c-9553-8be594f17b76,STING pathway in Kawasaki-like disease and COVID-19 WP4961,STING pathway in Kawasaki-like disease and COVID-19,WP4961,https://www.wikipathways.org/index.php/Pathway:WP4961
b447cdab-6da2-5f76-a33d-460654601585,Striated Muscle Contraction Pathway WP383,Striated Muscle Contraction Pathway,WP383,https://www.wikipathways.org/index.php/Pathway:WP383
0ddccc92-277c-5aa6-a69d-4b3af401906e,Structural Pathway of Interleukin 1 (IL-1) WP2637,Structural Pathway of Interleukin 1 (IL-1),WP2637,https://www.wikipathways.org/index.php/Pathway:WP2637
29f2a79d-4085-50f9-a2f7-f141800a109d,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,WP706,https://www.wikipathways.org/index.php/Pathway:WP706
051002f9-cd6c-5be0-9e58-1e03cad0688e,Sulfation Biotransformation Reaction WP692,Sulfation Biotransformation Reaction,WP692,https://www.wikipathways.org/index.php/Pathway:WP692
97ed9de8-3771-514b-906f-e15a161eafec,Sulindac Metabolic Pathway WP2542,Sulindac Metabolic Pathway,WP2542,https://www.wikipathways.org/index.php/Pathway:WP2542
4191f7d4-0fd2-579d-8000-529eaa0c79b1,Supression of HMGB1 mediated inflammation by THBD WP4479,Supression of HMGB1 mediated inflammation by THBD,WP4479,https://www.wikipathways.org/index.php/Pathway:WP4479
4d2bfcdf-2e1d-5e8f-bd56-1f0031ece1f4,Synaptic signaling pathways associated with autism spectrum disorder WP4539,Synaptic signaling pathways associated with autism spectrum disorder,WP4539,https://www.wikipathways.org/index.php/Pathway:WP4539
d414ea9a-0240-54d3-93a8-1c34e023531e,Synaptic Vesicle Pathway WP2267,Synaptic Vesicle Pathway,WP2267,https://www.wikipathways.org/index.php/Pathway:WP2267
89d18008-eb6c-5072-b556-e840b36fe8d2,Synthesis and Degradation of Ketone Bodies WP311,Synthesis and Degradation of Ketone Bodies,WP311,https://www.wikipathways.org/index.php/Pathway:WP311
2d5e523d-a879-599f-aad6-f2e103fdacd7,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection,WP3863,https://www.wikipathways.org/index.php/Pathway:WP3863
19d7f8d6-32a2-586b-8377-ae21b16a68e4,T-cell receptor (TCR) signaling pathway WP69,T-cell receptor (TCR) signaling pathway,WP69,https://www.wikipathways.org/index.php/Pathway:WP69
46714193-690c-560d-9f4a-d6933a451c69,T-Cell Receptor and Co-stimulatory Signaling WP2583,T-Cell Receptor and Co-stimulatory Signaling,WP2583,https://www.wikipathways.org/index.php/Pathway:WP2583
b2d8a0cb-078b-5157-bcf1-18533b8045f1,Tamoxifen metabolism WP691,Tamoxifen metabolism,WP691,https://www.wikipathways.org/index.php/Pathway:WP691
0b553537-1591-5f4d-9cc9-83fe27c5a59d,Target Of Rapamycin (TOR) Signaling WP1471,Target Of Rapamycin (TOR) Signaling,WP1471,https://www.wikipathways.org/index.php/Pathway:WP1471
a0f990f3-0cd0-5c62-94ae-9de586a2ba0a,TCA Cycle (aka Krebs or citric acid cycle) WP78,TCA Cycle (aka Krebs or citric acid cycle),WP78,https://www.wikipathways.org/index.php/Pathway:WP78
dcabac39-1414-59c7-b569-790920a254fd,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc),WP2453,https://www.wikipathways.org/index.php/Pathway:WP2453
59c15696-8fcd-5939-a2d9-5faca3a44015,TCA cycle in senescence WP5050,TCA cycle in senescence,WP5050,https://www.wikipathways.org/index.php/Pathway:WP5050
6007e9a5-aa3b-5376-8e19-bf5c7e7d783c,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer,WP2868,https://www.wikipathways.org/index.php/Pathway:WP2868
fbfb3c5b-081d-5c93-94b6-8cf9896e978d,TFs regulate miRNAs related to cardiac hypertrophy WP1559,TFs regulate miRNAs related to cardiac hypertrophy,WP1559,https://www.wikipathways.org/index.php/Pathway:WP1559
f563945c-2786-5079-86d8-b903d5c7f620,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition,WP3859,https://www.wikipathways.org/index.php/Pathway:WP3859
245aeecb-bbfd-5421-9b8b-e49e7ed824a4,TGF-beta receptor signaling in skeletal dysplasias WP4816,TGF-beta receptor signaling in skeletal dysplasias,WP4816,https://www.wikipathways.org/index.php/Pathway:WP4816
aa52ba89-e6ca-549f-b133-8f21d0ff8665,TGF-beta Receptor Signaling WP560,TGF-beta Receptor Signaling,WP560,https://www.wikipathways.org/index.php/Pathway:WP560
c071bfad-c0ad-5187-9819-e93dfda9f793,TGF-beta Signaling Pathway WP366,TGF-beta Signaling Pathway,WP366,https://www.wikipathways.org/index.php/Pathway:WP366
126e9fe1-ac42-58a9-a8d0-e61de2f9d7ed,Tgif disruption of Shh signaling WP3674,Tgif disruption of Shh signaling,WP3674,https://www.wikipathways.org/index.php/Pathway:WP3674
623f7234-dab5-5fb9-bb57-8ea1543da8bd,The alternative pathway of fetal androgen synthesis WP4524,The alternative pathway of fetal androgen synthesis,WP4524,https://www.wikipathways.org/index.php/Pathway:WP4524
5e1cca7e-1147-53f8-9b8f-54eda30c1e2f,The influence of laminopathies on Wnt signaling WP4844,The influence of laminopathies on Wnt signaling,WP4844,https://www.wikipathways.org/index.php/Pathway:WP4844
48358e55-fdb4-536f-be05-9e9d6fc4c105,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies,WP4879,https://www.wikipathways.org/index.php/Pathway:WP4879
8a757166-cff0-5210-adc0-b578256553a2,Thermogenesis WP4321,Thermogenesis,WP4321,https://www.wikipathways.org/index.php/Pathway:WP4321
0b3bbdb4-4329-5bd1-a5c1-a33d7f1a0d0d,Thiamine metabolic pathways WP4297,Thiamine metabolic pathways,WP4297,https://www.wikipathways.org/index.php/Pathway:WP4297
d3729993-709f-5f3a-a14c-d67bc218b8ba,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway,WP2203,https://www.wikipathways.org/index.php/Pathway:WP2203
e120ee82-bbe9-53d2-bce4-50060b1a281a,Thyroid hormones production and their peripheral downstream signaling effects WP4746,Thyroid hormones production and their peripheral downstream signaling effects,WP4746,https://www.wikipathways.org/index.php/Pathway:WP4746
a8a8ff26-932a-5d73-ab33-e2489dacaf77,Thyroid stimulating hormone (TSH) signaling pathway WP2032,Thyroid stimulating hormone (TSH) signaling pathway,WP2032,https://www.wikipathways.org/index.php/Pathway:WP2032
e169cb3d-0e5d-54d1-9518-116255579bfa,Thyroxine (Thyroid Hormone) Production WP1981,Thyroxine (Thyroid Hormone) Production,WP1981,https://www.wikipathways.org/index.php/Pathway:WP1981
2215561b-d854-5b70-a648-d8265413563b,TLR4 Signaling and Tolerance WP3851,TLR4 Signaling and Tolerance,WP3851,https://www.wikipathways.org/index.php/Pathway:WP3851
088d6a8d-4179-5261-8519-21686ceb7799,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway,WP2036,https://www.wikipathways.org/index.php/Pathway:WP2036
e378d086-3ac4-5c13-a843-b82c503e4873,TNF-alpha signaling pathway WP231,TNF-alpha signaling pathway,WP231,https://www.wikipathways.org/index.php/Pathway:WP231
f7fa339f-dc83-53e3-82f3-7d28cadf40a4,Toll-like Receptor Signaling Pathway WP75,Toll-like Receptor Signaling Pathway,WP75,https://www.wikipathways.org/index.php/Pathway:WP75
fd118f1c-703c-59e3-a4fd-d1b85458b50d,Toll-like Receptor Signaling related to MyD88 WP3858,Toll-like Receptor Signaling related to MyD88,WP3858,https://www.wikipathways.org/index.php/Pathway:WP3858
58230672-f5dc-5b61-b7a2-0c2873885bfa,TP53 network WP1742,TP53 network,WP1742,https://www.wikipathways.org/index.php/Pathway:WP1742
ba98e494-bcda-5268-958d-26f1f38541d6,Trans-sulfuration and one-carbon metabolism WP2525,Trans-sulfuration and one-carbon metabolism,WP2525,https://www.wikipathways.org/index.php/Pathway:WP2525
a39be947-03df-56dd-ad5f-0375e6b73d97,Trans-sulfuration pathway WP2333,Trans-sulfuration pathway,WP2333,https://www.wikipathways.org/index.php/Pathway:WP2333
bbb2706e-dee6-5643-a6db-5fd4d2c794ca,Transcription co-factors SKI and SKIL protein partners WP4533,Transcription co-factors SKI and SKIL protein partners,WP4533,https://www.wikipathways.org/index.php/Pathway:WP4533
ad487d52-64b7-56f8-8809-42708e86e01b,Transcription factor regulation in adipogenesis WP3599,Transcription factor regulation in adipogenesis,WP3599,https://www.wikipathways.org/index.php/Pathway:WP3599
b02aa9e7-d940-58fa-b9e9-8fe39311aec9,Transcriptional cascade regulating adipogenesis WP4211,Transcriptional cascade regulating adipogenesis,WP4211,https://www.wikipathways.org/index.php/Pathway:WP4211
6bcf488b-7bf7-5e88-9880-b8eebaf26a73,Translation Factors WP107,Translation Factors,WP107,https://www.wikipathways.org/index.php/Pathway:WP107
02e96c6a-a4ff-53d0-b333-92b72ae58253,Translation inhibitors in chronically activated PDGFRA cells WP4566,Translation inhibitors in chronically activated PDGFRA cells,WP4566,https://www.wikipathways.org/index.php/Pathway:WP4566
3195c283-b403-5501-9988-395d93f6d5cf,Triacylglyceride synthesis WP325,Triacylglyceride synthesis,WP325,https://www.wikipathways.org/index.php/Pathway:WP325
a061b77b-fc2b-5482-8cd1-f5bc8f7e7b0a,Tryptophan catabolism leading to NAD+ production WP4210,Tryptophan catabolism leading to NAD+ production,WP4210,https://www.wikipathways.org/index.php/Pathway:WP4210
849ecf8f-604b-52f7-a0b1-0a168a9380d8,Tryptophan metabolism WP465,Tryptophan metabolism,WP465,https://www.wikipathways.org/index.php/Pathway:WP465
d1c80ef9-840e-5fc2-b663-50a7da26b6d5,Tumor suppressor activity of SMARCB1 WP4204,Tumor suppressor activity of SMARCB1,WP4204,https://www.wikipathways.org/index.php/Pathway:WP4204
779f9e22-c47c-567b-8d8f-408acedd4c78,Type 2 papillary renal cell carcinoma WP4241,Type 2 papillary renal cell carcinoma,WP4241,https://www.wikipathways.org/index.php/Pathway:WP4241
e1ce4d97-1585-5780-9151-bb7ef40adff1,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,Type I collagen synthesis in the context of Osteogenesis imperfecta,WP4786,https://www.wikipathways.org/index.php/Pathway:WP4786
8ca5cebe-c199-5750-86ab-4dae4a288b94,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,Type I interferon induction and signaling during SARS-CoV-2 infection,WP4868,https://www.wikipathways.org/index.php/Pathway:WP4868
2be87f6b-69a2-56de-9f51-ea550b8a4d28,Type II diabetes mellitus WP1584,Type II diabetes mellitus,WP1584,https://www.wikipathways.org/index.php/Pathway:WP1584
108eac06-f370-599b-8b0f-c102e3753cfc,Type II interferon signaling (IFNG) WP619,Type II interferon signaling (IFNG),WP619,https://www.wikipathways.org/index.php/Pathway:WP619
dee2f424-8cdf-57b4-8205-062a04d1dd8e,Type III interferon signaling WP2113,Type III interferon signaling,WP2113,https://www.wikipathways.org/index.php/Pathway:WP2113
e9abe4b6-f963-5f23-8623-97741a91465c,TYROBP causal network in microglia WP3945,TYROBP causal network in microglia,WP3945,https://www.wikipathways.org/index.php/Pathway:WP3945
fe079978-ee28-58bd-ac47-b448f48bf72f,Unfolded protein response WP4925,Unfolded protein response,WP4925,https://www.wikipathways.org/index.php/Pathway:WP4925
67a42624-9b4f-54f7-8b93-f918fb030642,Urea cycle and associated pathways WP4595,Urea cycle and associated pathways,WP4595,https://www.wikipathways.org/index.php/Pathway:WP4595
bc7f1c85-882f-5986-b110-20a335fe2977,Urea cycle and metabolism of amino groups WP497,Urea cycle and metabolism of amino groups,WP497,https://www.wikipathways.org/index.php/Pathway:WP497
d315cbb7-b9a2-56d7-9a88-594b30aa5a6d,Urea cycle and related diseases WP4571,Urea cycle and related diseases,WP4571,https://www.wikipathways.org/index.php/Pathway:WP4571
aa3a581e-2a36-5faf-a305-f03a543bf9fa,Valproic acid pathway WP3871,Valproic acid pathway,WP3871,https://www.wikipathways.org/index.php/Pathway:WP3871
cea6a21f-83c3-5559-8ffb-44e3001aca3b,VEGFA-VEGFR2 Signaling Pathway WP3888,VEGFA-VEGFR2 Signaling Pathway,WP3888,https://www.wikipathways.org/index.php/Pathway:WP3888
9f1bb7d7-cbcd-5647-8ed4-645807549db1,Vitamin A and carotenoid metabolism WP716,Vitamin A and carotenoid metabolism,WP716,https://www.wikipathways.org/index.php/Pathway:WP716
c4474a4a-ebb0-5ecd-8f99-2c0f6507961b,Vitamin B12 Disorders WP4271,Vitamin B12 Disorders,WP4271,https://www.wikipathways.org/index.php/Pathway:WP4271
66173ba2-096f-5e0d-acb2-7be2546b547a,Vitamin B12 metabolism WP1533,Vitamin B12 metabolism,WP1533,https://www.wikipathways.org/index.php/Pathway:WP1533
b980ddef-dbdb-54c5-92e5-0ad9fa4f64dc,Vitamin B6-dependent and responsive disorders WP4228,Vitamin B6-dependent and responsive disorders,WP4228,https://www.wikipathways.org/index.php/Pathway:WP4228
ce0ad146-9c25-5e59-a7c3-05bd2a5e2b1f,Vitamin D in inflammatory diseases WP4482,Vitamin D in inflammatory diseases,WP4482,https://www.wikipathways.org/index.php/Pathway:WP4482
076fb5b5-d7ad-5e9a-a51d-9504edc0d6e7,Vitamin D Metabolism WP1531,Vitamin D Metabolism,WP1531,https://www.wikipathways.org/index.php/Pathway:WP1531
24abf407-f128-5e1a-87cc-c194cf69e4a1,Vitamin D Receptor Pathway WP2877,Vitamin D Receptor Pathway,WP2877,https://www.wikipathways.org/index.php/Pathway:WP2877
b52c84b4-e982-53e2-9a02-0e82e92ca45c,Vitamin D-sensitive calcium signaling in depression WP4698,Vitamin D-sensitive calcium signaling in depression,WP4698,https://www.wikipathways.org/index.php/Pathway:WP4698
49854a23-fb50-5857-aff5-2f3a6a241448,White fat cell differentiation WP4149,White fat cell differentiation,WP4149,https://www.wikipathways.org/index.php/Pathway:WP4149
39cf652a-98d4-5124-b09a-7e1b3e2a4f32,Wnt signaling in kidney disease WP4150,Wnt signaling in kidney disease,WP4150,https://www.wikipathways.org/index.php/Pathway:WP4150
5d304ec2-26d4-57cc-b67c-594ed5355705,Wnt signaling pathway and pluripotency WP399,Wnt signaling pathway and pluripotency,WP399,https://www.wikipathways.org/index.php/Pathway:WP399
6a6f2f25-f59a-5fff-bcef-4474895e3ccb,Wnt Signaling Pathway WP363,Wnt Signaling Pathway,WP363,https://www.wikipathways.org/index.php/Pathway:WP363
7ce6c186-d42d-563b-82d9-e1f47de240cb,Wnt signaling WP428,Wnt signaling,WP428,https://www.wikipathways.org/index.php/Pathway:WP428
ba7d777b-f701-517a-839c-d39393865a1c,Wnt/beta-catenin signaling pathway in leukemia WP3658,Wnt/beta-catenin signaling pathway in leukemia,WP3658,https://www.wikipathways.org/index.php/Pathway:WP3658
389e5e9d-bc27-59d8-abfe-495ffd384638,Zinc homeostasis WP3529,Zinc homeostasis,WP3529,https://www.wikipathways.org/index.php/Pathway:WP3529
